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Abstract:

PERCEIVED STRESS AND SURGICAL WOUND CYTOKINE PATTERNS
By Valentina Sage Lucas, RN, MS, ANP-BC
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2012
Major Director: Nancy L. McCain, RN, DSN, FAAN
Department of Adult Health and Nursing Systems, School of Nursing

Normal wound healing is a complex process that occurs in overlapping phases and
depends upon interactions of the patient, environment and a large number of cells, growth
factors, cytokines, chemokines, and other biochemical mediators. Psychological stress
has been shown to adversely affect the normal wound healing process through its impact
on cellular immunity. Cellular immunity impacts wound healing through the production
and regulation of many of the above biochemical mediators of wound healing. The
purpose of this pilot study was to examine the relationships among pre- and postoperative psychological stress experienced by women who were undergoing either
immediate or delayed breast reconstruction following mastectomy for breast cancer and
influence of that stress on wound healing, specifically the biochemical mediators of
wound healing in the local wound environment. An integration of Lazarus and Folkman’s
cognitive appraisal model of stress and coping and the psychoneuroimmunology model

iv

proposed by McCain, Gray, Walter and Robins (2005) served as the theoretical
framework for the research. A descriptive non-experimental design was used, with
samples collected over time to describe biochemical patterns in surgical wounds of
women undergoing autologous breast reconstruction. Biochemical data were collected
preoperatively, as well as at 24, 48, 72 and 96 hours postoperatively. Psychological stress
instruments were administered pre-operatively and 48 hours post-operatively. Although
subjects overall displayed low levels of psychological stress, meaningful wound fluid
biochemical mediator patterns were detected. This study adds to our knowledge
concerning wound fluid chemical mediators present in the local wound environment over
time.
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CHAPTER 1
Introduction

Research shows a strong relationship between psychological stress and health,
including but not limited to delayed wound healing (Broadbent, Petrie, Alley & Booth,
2003; Glaser, Kieclt-Glaser, Marchucha, MacCallum, Laskowski & Malarkey, 1999;
Ebrecht, Hestall, Kirtley, Taylor, Dyson & Weinman, 2003), poor surgical outcomes
(Linn, Linn & Klimas, 1988), and decreasing immune system functioning (Padgett &
Glaser, 2003; Lusk & Lash, 2005; Starkweather, 2007; Von Ah, Kaan & Carpenter,
2007). Stress has been implicated in the lay literature as the cause of vague body aches,
headaches, stomach upset, loss of interest in sex, depressed mood, and eating disorders.
Most diseases are caused by multiple factors, so it is most likely that stress alone does not
cause poor health outcomes, but is one factor that adversely affects health.
The diagnosis of cancer can produce an “existential plight”, bringing feelings of
shock, disbelief, and emotional turmoil (Weisman & Worden, 1976). Surgical procedures
have been identified as a “high-stakes” stressor (Borah, Rankin & Wey, 1999). Women
living with a diagnosis of breast cancer and facing mastectomy and subsequent surgical
reconstruction may experience psychological reactions produced by the anticipation of
surgery and treatment for their disease. As patients navigate numerous medical “stops”
on their way to surgery, such as radiology studies, biopsy, multiple physical exams by a
variety of consultants and laboratory studies (Frierson & Anderson, 2006), they are
1

dealing with thoughts of body image, family issues, career and employment concerns,
and thoughts of mortality, all of which can cause significant stress and anxiety. One study
reported as much as 50% of women with breast cancer experience sub-clinical symptoms
of Post Traumatic Stress Disorder (Levine, Eckhardt & Targ, 2005).
Certainly women with breast cancer experience stress. Extended activation of the
stress response can lead to chronic activation of the hypothalamic-pituitary-adrenal axis
and the sympathetic-adrenal-medullary axis, leading to chronic production of
glucocorticoid hormones and catecholamines, resulting in a dysregulation of immune
system functioning (Padgett & Glaser, 2003). Cellular immunity has an important role in
the regulation of wound healing through the production and regulation of cytokines, and
chemokines, which control and regulate many processes in the body, of which wound
healing is one. This dissertation will first present in Chapter 2 a review of the literature as
it pertains to psychological stress and wound healing in humans; this chapter was
published in Wounds in 2011. A basic review of the phases of wound healing is included
in this publication. Chapter 3 is the defended and approved IRB research proposal,
outlining the research plan, design, and steps taken to insure protection of research
subjects for the dissertation research. The findings of this research are detailed in the
manuscript presented as Chapter 4. This work is a step forward to understanding
relationships of various chemical mediators in the local wound environment and to our
knowledge, is the first to characterized surgical wound fluid cytokine patterns over time.
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Abstract: The phenomenon of stress is a common human experience
frequently blamed for much of the ill health individuals experience.
Much focus has been given to the effect of stress on health and wellness. Research demonstrates a strong relationship between psychological stress and health including, but not limited to, poor surgical
outcomes and a decrease in immune system functioning. The skin is
the largest organ of the human body and is responsible for thermoregulation, vitamin D production, and protection from fluid loss,
pathogens, ultraviolet radiation, and mechanical injury. The skin contains a vast supply of sensory nerves, providing sensory input on pain,
temperature, pressure, and pleasure. Timely wound healing is of
utmost importance because of the skin’s vital protective and regulatory functions. Psychological stress has been shown to negatively impact
wound healing, both directly and indirectly. The purpose of this review
is to identify existing knowledge about the relationship between psychological stress and wound healing in order to provide the best evidence currently available on which to base recommendations for
future research and to guide practice.
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he phenomenon of stress is a common human experience frequently
blamed for much of the ill health individuals experience. Much focus
has been given to the effect of stress on health and wellness. Stress
can be physical or psychological, acute or chronic. Stress is often thought of
as the human response to a stimulus or more specifically a “stressor” in one’s
environment. The response is often based on an individual’s appraisal of the
situation, the individual’s coping behaviors, and the resources available to
the individual. Lazarus and Folkman1 specifically define stress as a “relationship between the person and the environment that is appraised by the person as taxing or exceeding his or her resources and endangering his or her
wellbeing.” Appraisal and coping are key to this definition and lead to the
subjective experience of stress. The degree of perceived threat determines
the magnitude of the stress response to the environmental event. When individuals can no longer cope with stressful situations, affective, behavioral, and
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physiological changes result.2 Research demonstrates a
strong relationship between psychological stress and
health including, but not limited to, alteration in immune
system functioning,3–6 poor surgical outcomes,7 alterations in metabolism, increased risk of obesity,8,9 and
increased risk of developing cardiovascular disease.10,11
The skin is the largest organ of the human body and is
responsible for protection from pathogens, ultraviolet
radiation, and mechanical injury.Additionally, the skin provides protection from fluid loss and has an active role in
thermoregulation, as well as vitamin D production. The
slightly acidic pH of the skin serves as a protective barrier against bacterial and fungal invasions.The skin contains
a vast supply of sensory nerves that provide sensory input
regarding pain, temperature, pressure, and pleasure.12,13
Timely wound healing is of utmost importance because
of the skin’s vital protective and regulatory functions.
Wounds of the skin typically progress in a predictable
and timely manner. When the normal phases of wound
healing are interrupted, chronic wounds develop, which
leads to an increased risk of infection, prolonged hospital stays, and decreased quality of life. Chronic wounds
account for a significant amount of healthcare spending
in the United States, amounting to an estimated $5 to $9
billion each year.14
Stress has been shown to have a negative impact on
wound healing.15–17 Although both the direct and indirect
mechanisms of stress may be responsible for slowed
healing, the most prominent impact is through the
effects of stress on cellular immunity. Cellular immunity
has an important role in the regulation of wound healing
through the production and regulation of pro-inflammatory and anti-inflammatory cytokines. Cytokines, specifically platelet derived growth factor (PDGF), tumor necrosis factor (TNF-α),
), interferon-gamma (IFN(IFN-γ), various
interleukins (IL-1α,
α,, IL-1β,
α
IL-1β,, IL-6, IL-8), basic fibroblast
IL-1β
growth factor (bFGF), epidermal growth factor (EGF),
and transforming growth factor beta (TGF(TGF-β) potentially
mediate many of the complex interactions involved in
wound healing.
The purpose of this review is to identify existing
knowledge about the relationship between psychological stress and wound healing in order to provide the best
evidence currently available on which to base recommendations for future research and to guide practice.
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described according to its etiology (surgical, venous, neuropathic etc.), location (lower extremity, abdominal, foot,
etc.) or by the duration (acute versus chronic).19 Normal
cutaneous wound healing is a complex process that
occurs in overlapping phases and depends upon interactions not only between the person and environment, but
on multiple interactions among a large number of cells
and chemical mediators including cytokines, hormones,
and neurotransmitters. These phases do not occur in isolation, but are dynamic and overlapping. Even so, wound
healing can be characterized by three phases: inflammatory, proliferative, and remodeling. The inflammatory
phase begins within seconds of injury and lasts anywhere from 2–5 days. Blood vessel disruption activates
platelets and triggers the release of clotting factors. The
occurrence of vasoconstriction and platelet aggregation
stops bleeding and provides a provisional matrix for cellular migration into the injured area.20–22 The large number of platelets in the clot will degranulate and release
numerous growth factors and cytokines.
Approximately 24 hours after injury, neutrophils and
macrophages begin to remove nonviable tissue, debris,
and bacteria from the wound through the release of
enzymes and phagocytosis.23 In addition to cleaning up
the wound bed of nonviable tissue, macrophages and
neurtrophils have been shown to express several proinflammatory cytokines. Proinflammatory cytokines are
some of the earliest signals to activate and recruit inflammatory cells and fibroblasts to the injury site causing
inflammation and vasodilatation, which increases blood
vessel permeability and allows easy passage of fluid and
phagocytes. Platelet derived growth factor (PDGF) is
released by the platelets, stimulating the growth of blood
vessels and new structural tissue.20,24,25 Cytokines are also
responsible for activation of keratinocytes found at
wound edges, hair follicles, sebaceous and sweat glands.
Keratinocytes are the most prevalent cell type of epithelium and begin to migrate and proliferate within 24
hours after injury, paving the way for the formation of
new epithelium.26–28 This process continues on into the
proliferative phase of wound healing.
Over the next 2 days to 3 weeks, the proliferative
phase begins. Fibroblasts and other cell types begin to lay
down the ground substances and collagen fibers in the
site of injury. Various chemical mediators such as PDGF
stimulate angiogenesis, which is marked by the formation of granulation tissue consisting of new capillary
loops in a matrix of collagen and ground substance.
Keratinocytes are actively carrying out re-epithelializa-

How Wounds Heal

A wound can be defined “a disruption of the integrity
and function of tissues in the body”18 and can be further
6
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tion. Wound contraction is accomplished by the work of
the myofibroblasts.The wound is considered closed with
the establishment of a new epidermal covering.29 The
basement membrane, between the epidermis and the
dermis, is typically repaired 7–9 days after re-epithelialization and is essential for the restoration of skin integrity and function.22
Over the next 3 weeks to 2 years, the final phase of
wound healing takes place. In the maturation or remodeling phase, type III collagen is gradually replaced with
type I. Tensile strength increases as the collagen fibers
reorganize. Healed wounds result in a scar, which differs
somewhat from the original tissue, and has approximately 70%–80% of its original tensile strength.25
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• When individuals can no longer cope with stressful
situations, affective, behavioral, and physiological
changes result
• Although both the direct and indirect mechanisms
of stress may be responsible for slowed healing, the
most prominent impact is through the effects of
stress on cellular immunity mediated by cytokines
and growth factors

decreasing capillary permeability and inhibiting chemotaxis. Elevated cortisol levels have been found to inhibit
production of T cell-derived cytokines, such as interleukin 1.4,31
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Stress and Wound Healing

• For inclusion in this review, all studies had to have
at least one measure of stress, such as the
Perceived Stress Scale (PSS). Studies exploring the
relationship between other psychological factors,
such as depression or anxiety, were not included in
this review

It is well established that psychological stress modulates immune system functioning and a fully functioning
immune system is integral to timely and effective wound
healing. Numerous studies have explored the relationship between psychological stress and wound healing.
Although both human and murine models have been utilized in studying stress and wound healing, only studies
involving human subjects will be included here. For
inclusion in this review, all studies had to have at least
one measure of stress, such as the Perceived Stress Scale
(PSS). Studies exploring the relationship between other
psychological factors, such as depression or anxiety,
were not included in this review.
Systemic factors known to have negative effect on
wound healing were considered exclusion criteria and
were similar across all studies. Exclusion criteria most
commonly cited included tobacco use, diabetes, peripheral vascular disease (PVD), cardiovascular disease
(CVD), difficulty with wound healing in the past,
immunologically related problems, recent surgeries, previous psychiatric illnesses, and use of anti-inflammatory
medications with obvious immunological effects.
Smokers and individuals with frequent alcohol consumption were often excluded. Wound types consisted
of experimentally created wounds (eg, punch biopsy,
blister) or preexisting clinical wounds (surgical and leg
ulcers). Research utilized a variety of measures to evaluate the relationship between psychological stresses and
wound healing. This makes a comparison of studies
somewhat difficult since outcome measures varied. For
the purpose of this review, findings are grouped based on
how healing was assessed.

DU
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Often when we think of the stress response, we think
of the “Fight or Flight” response, whereby stressful
events trigger simultaneous activation of both the hypothalamic-pituitary-adrenal (HPA) axis in the central nervous system and the sympatho-adrenomedullary (SAM)
axis in the sympathetic nervous system.Activation of the
SAM axis stimulates the release of the catecholamines
epinephrine and norepinephrine, leading to an
increased heart rate, increased blood flow to skeletal
muscles, and an elevation in glucose metabolism. The
SAM pathway is faster and has a more immediate physiological effect. Activation of the SAM axis activates the
inflammatory response.
Activation of the HPA axis activates the release of corticotrophin-releasing hormone (CRH) from the hypothalamus and CRH then stimulates the release of adrenocorticotropin (ACTH) from the anterior pituitary, which
in turn triggers the release of the glucocorticoids from
the adrenal glands. In humans, this glucocorticoid is cortisol. Normal levels of glucocorticoids are believed to be
immunomodulatory. However, when stress increases levels of glucocorticoids, suppression of inflammatory and
immune responses occur.30 Cortisol has been shown to
decrease circulating leukocytes and inhibit the migration of leukocytes to the site of injury or infection by
78
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Digital Photography

evaluated using high-resolution ultrasound. A significant
negative correlation between speed of wound healing
and both the PSS scores (r = -0.59; P < 0.01) and the
General Health Questionnaire was found. Morning cortisol levels were highest in those individual whose
wounds were the slowest to heal.
Weinman et al37 utilized high-resolution ultrasound in
evaluating the healing of wounds placed on the hard pallet. A prospective, longitudinal design with random
assignment was used to test the ability of a disclosure
intervention to lower psychological stress associated
with a traumatic experience and to improve healing.
While the disclosure intervention did not have a significant effect on the PSS scores, participants who wrote
about emotional experiences had significantly faster
wound healing times (wounds ~11% smaller) than the
control group.

PL

IC

The most simple and straightforward method of
wound assessment is the use of digital photography. In a
study of the effectiveness of a 3-month exercise intervention program on wound healing, neuroendocrine
function, and perceived life stress, Emery et al32 used digital photography to assess wound healing. The wound
healing outcome measure was the ratio between the
areas of a standardized black dot applied next to the
wound. Photos were taken on a schedule and wound
healing was documented and considered positive as the
size of the wound decreased in relation to the applied
dot. A sample of 28 healthy men and women were randomized to either an exercise intervention group or a
control group. The wounds of individuals who participated in regular exercise healed significantly faster
(mean = 29.2, SE 9.0 days). All wounds for both groups
healed by week 7. Interestingly, this study found that
exercise improved healing yet did very little to improve
self-reported stress on the PSS. Salivary cortisol was elevated in the exercise group but did not change in the
nonexercise group. The authors proposed that the
increased responsiveness of cortisol to stress following
exercise suggests that exercise contributes to enhanced
neuroendocrine responsiveness.32

Hydrogen Peroxide Foaming Test

DU

Two studies identified for this review utilized the
hydrogen peroxide response test to assess wound healing. This method measures the quality of the epithelial
barrier. The process involves the application of a small
amount of hydrogen peroxide to the wounded area.
Catalase, an enzyme found in connective tissue, liberates
oxygen gas and water from the hydrogen peroxide. If the
epithelial layer is disrupted, then foaming is visible at the
wound site as oxygen is liberated. If the epithelial layer is
intact, the diffusion of hydrogen peroxide does not take
place and therefore little or no foaming is visible.38–40
Therefore, if there is no foaming present after application, the wound is considered healed.
Marucha et al40 evaluated the effects of examination
stress on dental students’ ability to heal a mucosal
wound. Each subject served as his or her own control.
Two wounds were placed on the hard palate, the first
during summer vacation. The second wound was placed
on the contralateral side 3 days before the first major
examination of the term. Daily photographs and foaming
response to hydrogen peroxide were used to measure
healing. Students took significantly longer to heal during
the examination period (mean 7.82 days) compared to
the vacation period (mean 10.91 days) [F(1,10) = 28.47;
P < 0.001] Students scored higher on the PSS and had
lower whole blood IL-1β levels during examinations. The
decrease in IL-1β demonstrates the decrease in immune
function and a possible mechanism underlying the relationship of examination stress to wound healing.
Kiecolt-Glaser et al38 used hydrogen peroxide foam

High Resolution Ultrasound
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Ultrasounds use sound waves to produce images of
soft tissue anatomy. Basically, a probe is placed over the
area of interest and transmits sound waves into the body.
When these sound waves hit a boundary between
acoustically different tissues, such as bone versus soft tissue, a proportion of the energy, known as an echo, is
reflected back.33 High-resolution ultrasound typically
involves frequencies of 15 megahertz (MHz) or higher.
Depth of penetration is lost with higher frequencies, but
resolution is improved. High-resolution ultrasound is useful in that it can show the fluid content of various tissues. Greater fluid content results in a decrease in the
echogenicity in the tissue being observed. The use of
high-resolution ultrasound has been shown to be effective in assessing dermal wounds.34–36
Ebrecht et al17 used a prospective, longitudinal, observational design to examine the relationship between perceived life stress and impaired wound healing.
Psychometric testing included the PSS, the General
Health Questionnaire, and the UCLA Loneliness scale.
Four 4-mm punch biopsy wounds were placed on the
upper arm of nonsmoking males, and wound healing was

8
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the routine manovac drain placed at the time of surgery.
Higher reported preoperative psychological stress predicted impaired cellular wound repair processes in the
early postoperative period. For example, higher preoperative stress significantly predicted lower levels of IL-1 in
the wound fluid (β = -0.44; P = 0.03). Greater worry about
the surgery predicted lower levels of matrix metalloproteinase-9 in the wound fluid (β
(β = -0.38; P = 0.03), a more
painful recovery (β
(β = 0.51; P = 0.002), and slower recovery (β = 0.43; P = 0.01). Neither stress nor worry predicted lower levels of IL-6 levels in the wound fluid.
Interestingly, researchers did not exclude smokers.
Smokers had higher levels of peripheral blood MMP-9
concentrations. Prolonged MMP-9 elevation has been
associated with chronic non-healing wounds.44 Lower
cytokines were also associated with higher cortisol levels.
Lastly, Kiecolt-Glaser et al45 explored the effect of hostile marital relationships on wound healing.A group of 42
healthy married couples, aged 22 to 77 years (mean
37.04) who were married a mean of 12.55 years, were
enrolled in an experimental cross-over study. Couples
were engaged in a structured social support interaction
during the first phase of the study, and in the second
phase, were asked to discuss a marital disagreement.
Psychological evaluations included the Positive and
Negative Affect Schedule (PANAS) and the Marital
Adjustment Test, which provided data on marital satisfaction (higher scores indicate higher satisfaction). The
Rapid Marital Coding System provided data on behavior
during both phases of the study. Wound fluid was evaluated for changes in cytokine levels. In addition, wound
healing was measured by the rate of transepidermal
water loss (TEWL) using an evaporimeter, which is a noninvasive objective method to evaluate changes in the
stratum corneum barrier function of the skin.46 They
found that couples’ blister wounds healed more slowly
following a single 30-minute marital conflict discussion
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test to evaluate the effects of psychological stress caused
by caring for a relative with Alzheimer’s disease on
wound healing. Healthy female caregivers and controls
were studied simultaneously, matched for age and
income. Complete wound healing of a 3.5-mm punch
biopsy, as indicated by lack of foaming after the application of hydrogen peroxide, took significantly longer in
caregivers (mean 48.7 days, SE = 2.9) than controls
(mean 39.3 days, SE = 3.0). Wound healing took on average 9 days longer in caregivers than in controls. In addition, caregivers reported significantly more stress on the
PSS than did control participants on study entry (20.5, SE
= 1.6 versus 13.7, SE = 1.5, P < 0.002). There was no significant change during the study, nor was there an interaction between group and time.

Wound Fluid Analysis
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Since numerous chemical mediators and cell types are
involved in the complex process of wound healing,
analysis of wound fluid provides some insight into the
extracellular environment of the wound.41,42 Wound fluid
characterization provides the opportunity to obtain
information reflecting the status of the wound at specific time points, and holds potential for the development
of specific biomarkers of impaired healing.43 Analysis of
wound fluid provides an opportunity to potentially connect the mechanisms of psychological stress to cellular
mechanisms in the local wound site.
In one prospective, longitudinal, observational study,
Glaser et al16 assessed the relationship between perceived life stress and the production of proinflammatory
cytokines at the wound site. Blister wounds were created on 36 healthy female subjects and wound fluid was
analyzed. Psychological tests included the 10-item
Perceived Stress Scale (PSS), the Positive and Negative
Affect Schedule, and the Psychiatric Epidemiological
Research Inventory Life Events Scale. Health-related
behaviors were also assessed. Women reporting greater
stress had lower production of IL-1α
IL-1 [F(1,32) = 5.73, P <
0.03] and IL-8 [F(1,32) = 5.31, P <0.03] in the wound
blister fluid.
In a second prospective longitudinal study, Broadbent
et al15 evaluated the relationship between preoperative
stress and worry and wound healing in patients undergoing routine surgical repair for an inguinal hernia.
Psychological measures included the PSS, the Worry
Visual Analogue Scale, and the Mental Health Index.
Wound healing was determined through changes in
cytokine profiles of surgical wound fluid collected from

KEYPOINTS

O

• This review provides but a glimpse of what is known
and what is still left to be discovered in the exciting
area of psychological stress and wound healing.
Other psychological mediators, such as depression
and anxiety, have been shown to slow wound healing and should be explored further
• Future work to examine the exact mechanisms of
pro-inflammatory and anti-inflammatory cytokines
will shed additional light on the mechanisms of
stress on wound healing
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3.
4.

Conclusion

5.

Clearly, there are substantial data in human studies to
suggest that psychological stress and the subsequent
effect on immune system disruption can impact wound
healing. The purpose of this article is to serve as a foundation and a review of the existing literature on the relationship of psychological stress and wound healing in
humans. Additionally, a review of available tools to measure wound healing for nursing research was presented.
This article provides but a glimpse of what is known and
what is still left to be discovered in the exciting area of
psychological stress and wound healing. Other psychological mediators, such as depression and anxiety, have
been shown to slow wound healing47–49 and should be
explored further. Psychological stress can lead to
unhealthy behaviors which may impact wound healing
such as smoking,50 poor nutrition,51 and altered sleep.52
For example, Rose et al52 point out that stress can negatively impact sleep, leading to disturbed sleep patterns
and a reduction in growth hormones, which may downregulate the tissue repair response.
Although numerous factors play a role in whether or
not a wound heals, such as nutrition, underlying health
conditions and appropriate care, it is clear that cytokines
play a crucial role as well. If dysregulation of the various
cytokines occurs, a potential disruption of normal
wound healing results, leading to delayed healing and
increased risk of infection and wound complications.
Future work to examine the exact mechanisms of proinflammatory and anti-inflammatory cytokines will shed
additional light on the mechanisms of stress on wound
healing. Examination of wound fluid holds the potential
to identify biomarkers of wound healing and subsequently provide diagnostic information on the wound
environment to improve treatment modalities.
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“Special Consent Provisions.” Complete that Section if applicable. When other Sections are not applicable, list the
Section Heading and indicate “N/A.”
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number or date, and page numbers.

DO NOT DELETE SECTION HEADINGS OR THE INSTRUCTIONS.
I. Title

A Pilot Study of Perceived Stress and Surgical Wound Cytokine Patterns
II. STAFFING
A. In the table below (add additional rows as needed), indicate: (1) key project personnel including the principal
investigator and individuals from other institutions, (2) their qualifications, and (3) a brief description of their
responsibilities.
NAME OF INDIVIDUAL
Nancy McCain
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MS, RN, ANP-BC, PhD candidate
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R.K. Elswick
Cindy Munro

MD
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Alumni Endowed Professor
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Faculty Advisor, Principle Investigator
Doctoral Candidate, Student
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Co-investigator, Committee Member
Co-investigator, Committee Member
Co-investigator, Committee Member

B. Describe the process that you will use to ensure that all persons assisting with the research are adequately
informed about the protocol and their research-related duties and functions.
The student and the principal investigator will meet approximately monthly throughout the proposal and dissertation
process to discuss study processes. Monthly communication between each investigator will ensure that they are
adequately informed about the protocol and each investigator’s study-related duties and functions.
III. CONFLICT OF INTEREST
Describe how the principal investigator and sub/co-investigators might benefit from the subject’s participation in
this project or completion of the project in general. Do not describe (1) academic recognition such as publications or
(2) grant or contract based support of VCU salary commensurate with the professional effort required for the
conduct of the project
The principal investigator and the student investigator for this pilot study will not benefit financially from subjects’
participation in the study or from completion of this project
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IV. RESOURCES
Briefly describe the resources committed to this project including: (1) time available to conduct and complete the
research, (2) facilities where you will conduct the research, (3 availability of medical or psychological resources that
participants might require as a consequence of the research (if applicable), and (4) financial support.

The student investigator is conducting this pilot study as her doctoral dissertation study and therefore is
committed through dissertation hours as required by the university. Recruitment will occur through the VCU
Health System Plastic Surgery Faculty Practice. Resources also include use of the Center for Biobehavioral
Clinical Research (CBCR) (supported by Center of Excellence grant #P30 NR011403, 2009-2014; R. Pickler,
PI) in Virginia Commonwealth University’s School of Nursing. The purpose of the CBCR is to enhance the
research programs related to improving biobehavioral outcomes at Virginia Commonwealth University (VCU)
School of Nursing. Center research focuses on the advancement of biobehavioral clinical science through
research related to biobehavioral mechanisms, management, and outcomes of complex constellations of
symptoms, including the commonly occurring symptom of fatigue. The pilot study will be funded by the PIs
School of Nursing research account.

V. HYPOTHESIS
Briefly state the problem, background, importance of the research, and goals of the proposed project.

Normal wound healing is a complex process that occurs in orderly and overlapping phases. However,
when these phases of wound healing are interrupted, chronic wounds develop, leading to increased risk of
infection, increased hospital stays, and decreased quality of life. Chronic wounds account for a significant
amount of healthcare spending in the United States, accounting for an estimated $5 to $9 billion each year
(Mandracchi, John, & Sanders, 2001).
Psychological stress has been shown to adversely affect the normal wound healing process through its
impact on cellular immunity. Cellular immunity has an important role in the regulation of wound healing
through the production and regulation of pro-inflammatory and anti-inflammatory cytokines. The diagnosis of
breast cancer is identified as a major life stressor (Kiecolt-Glaser & Glaser, 1994). Some studies indicate up to
80% of these women report significant stress during their initial treatment (Irvine, Vincent, Graydon &
Bubela, 1998). The goal of this pilot study project is to examine pre- and post-operative psychological stress
experienced by women who are undergoing mastectomy with immediate reconstruction or who have
undergone mastectomy and are having delayed reconstruction and the potential impact on wound healing,
specifically the chemical mediators of wound healing in the local wound environment.

VI. SPECIFIC AIMS
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The aim of the pilot study is to describe the relationships psychological stress and post-operative peripheral blood
cytokines and wound fluid cytokines among women undergoing mastectomy and immediate reconstruction surgery for
breast cancer.

VII. BACKGROUND AND SIGNIFICANCE
Include information regarding pre-clinical and early human studies. Attach appropriate citations.

Normal wound healing is a complex process that occurs in phases and depends upon interactions not
only between the patient and environment, but on multiple interactions among a large number of cells and
chemical mediators including cytokines, hormones and neurotransmitters. Acute wounds, such as traumatic
injuries and surgically created wounds often progress through orderly stages of wound healing and heal in a
timely fashion. Full thickness wound repair can easily be broken down into four phases, the hemostasis phase,
the inflammatory phase, the proliferative phase and the remodeling phase. The phases are not simple linear
events but overlap in time to some degree (Li, Chen, & Kirsner, 2007). The hemostasis phase, lasting from the
moment of injury to approximately 3 hours, is characterized by vasoconstriction and an inflow of clotting
factors and platelets, leading to platelet aggregation and formation of a hematoma, which stops bleeding and
provides a provisional matrix for cellular migration into the wounded site (Mehendale & Martin, 2001).
Platelets in the clot will degranulate and release numerous growth factors and cytokines. Platelet-derived
growth factor (PDGF) and transforming growth factor-beta (TGF-ß) are present in the wound bed at this time.
PDGF initiates the chemotaxis of macrophages, neutrophils, smooth muscle cells and fibroblasts. TGF-ß
attracts macrophages and stimulates them to produce additional cytokines. Cytokines, such as interleukin (IL)1α and IL-1β, recruit inflammatory cells and fibroblasts to the site of injury, causing inflammation and
vasodilatation, which increases blood vessel permeability, and allows easy passage of fluid and phagocytes.
PDGF is released by the platelets, stimulating the growth of blood vessels and new structural tissue (Morrison,
1997).
Approximately 24 hours after injury, neutrophils and macrophages begin to remove nonviable tissue
and bacteria from the wound through the release of enzymes and phagocytosis (Harding, Morris & Patel,
2002). In addition to removing nonviable tissue from the wound bed, macrophages and neurtrophils have been
shown to express several pro-inflammatory cytokines that serve as some of the earliest signals to activate
fibroblasts and keratinocytes (Hubner et al., 1996; Mehendale & Martin; 2001, Kindlen & Morrison; 1997).
This acute inflammatory phase typically last between 24 and 48 hours but can potentially persist for up to 2
weeks if necrotic tissue or high bacterial loads remain in the wound (Doughty & Sparks-Defriese, 2007; Li,
Chen, & Kirsner, 2007).
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At approximately 48 hours, fixed tissue monocytes are activated to become wound macrophages and
are essential for removing nonfunctional host cells, bacteria-filled neutrophils, damaged wound matrix, foreign
debris, and any remaining bacteria. These activated cells release PDGF and TGF-ß, attracting smooth muscle
cells and fibroblasts (Diegelmann & Evans, 2004).
Over approximately 2 days to 3 weeks, the proliferative phase begins. TGF-ß becomes an important
regulator of fibroblast function during this phase (Diegelmann & Evans, 2004). Fibroblasts and other cell
types begin to lay down the ground substances and collagen fibers in the site of injury. Various chemical
mediators such as PDGF stimulate angiogenesis, which is marked by the formation of granulation tissue
consisting of new capillary loops in a matrix of collagen and ground substance. Keratinocytes at the wound
edges and from the remnants of hair follicles, sebaceous glands and sweat glands divide and begin to migrate,
laying down new epithelium. Wound contraction occurs as a result of actions of the myofibroblasts.
Over the next 3 weeks to 2 years, the final phase of wound healing takes place. In the maturation or
remodeling phase, type III collagen is gradually replaced with type I. Tensile strength increases as the collagen
fibers reorganize. Healed wounds result in a scar, which differs somewhat from the original tissue and has
approximately 80% of the original tensile strength (Kindlen & Morrison, 1997).
Cytokines, specifically PDGF, tumor necrosis factor (TNF-α), interferon-gamma (IFN-γ), various
interleukins (IL- 1α, IL-1β, IL-6, IL-8), basic fibroblast growth factor (bFGF), epidermal growth factor (EGF),
and transforming growth factor-beta (TGF-β) mediate many of the complex interactions involved in wound
healing. Wounds typically progress in a predictable, timely manner. When the normal phases of wound
healing are interrupted, chronic wounds develop, leading to increased risk of infection, increased hospital
stays, and decreased quality of life. Chronic wounds account for a significant amount of healthcare spending in
the United States, estimated to be $5 to $9 billion each year (Mandracchi, John, & Sanders, 2001).
Stress and Wound Healing
Psychological stress has been shown to adversely affect the normal wound healing process through its
impact on cellular immunity. Cellular immunity has an important role in the regulation of wound healing
through the production and regulation of pro-inflammatory and anti-inflammatory cytokines. Numerous
studies have shown the relationship of psychological stress and wound healing. One such study examined the
effects of caregiver stress on wound healing, demonstrating that caregivers of individuals with dementia, who
reported significantly more stress that did controls, took longer to heal a 3.5mm punch biopsy wound
(Kiecolt-Glaser, 1995). Ebrecht et al. (2003) investigated the association between perceived stress and wound
healing by inflicting 4mm punch biopsy wounds on nonsmoking male subjects and then looked at time to
healed wound. A negative correlation between speed of wound healing and both the Perceived Stress Scale
and the General Health Questionnaire were found. Morning cortisol levels were highest in those individual
whose wounds were the slowest to heal. Glaser et al. (1999) found that women with higher perceived stress
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16

4

Rev. Date: 1-31-2010

IRB USE - Do Not Delete

scores had higher levels of salivary cortisol and significantly lower levels of IL-1 and IL-8 at the wound site.
In patients undergoing routine inguinal hernia repair, greater preoperative perceived stress significantly
predicted lower levels of IL-1 in the wound bed. Patients who reported higher levels of worry about the
operation had lower levels of matrix metalloproteinase-9 in the wound bed. Preoperative worry was also
associated with greater postoperative pain, poorer self-rating of recovery and a prolonged recovery time
(Broadbent, 2003). Rose et al (2001) point out that stress can negatively impact sleep, leading to disturbed
sleep patterns and a reduction in growth hormones, which may down-regulate the tissue repair response.
Although many factors play a role in whether or not a wound heals, such as proper nutrition, underlying health
conditions and appropriate care, it is clear that cytokines play a crucial role as well. If dysregulation of the
various cytokines occurs, a potential disruption of normal wound healing results, leading to delayed healing
and increased risk of infection.
Stress and Breast Cancer
According to the American Cancer Society, breast cancer is the most common malignancy diagnosis in
women. There were approximately 270,000 new cases of breast cancer in 2005. Approximately 62,000 deaths
were due to breast cancer in that same year (American Cancer Society, 2006). In 2004, approximately 62,000
women underwent mastectomy with some form of reconstruction (National Women’s Health Resource Center,
2005). The diagnosis of breast cancer is identified as a major life stressor (Kiecolt-Glaser & Glaser, 1994).
Some studies indicate up to 80% of these women report significant stress during their initial treatment (Irvine,
Vincent, Graydon & Bubela, 1998). While a study by Ananian et al. (2004) showed that 83% of women
choose immediate breast reconstruction, a study by Roth, Lowery, Davis and Wilkins (2005) found that there
was a relatively higher incidence of psychosocial impairment and functional disability in women seeking
immediate reconstruction following mastectomy. Studies have looked at psychological factors in women with
breast cancer and how such factors impact satisfaction with their reconstruction and quality of life (Roth et al.,
2005), yet little is known about the effect of pre- and post-operative stress associated with mastectomy and
reconstruction and its potential affects on wound healing.
Surgical wound complications such as infection, delayed closure and wound dehiscence are associated
with longer hospital stays, decreased quality of life, and increases in morbidity and mortality. Wounds that fail
to progress through the orderly healing process and convert to chronic wounds greatly increase cost of care
and lead to increases in morbidity and mortality.
By understanding the role of cytokines in the wound environment, we may better understand the
complex chemical interactions and the chemical mediators of healing in the wound. By gaining such
understanding, we may further develop technologies and interventions that impact the wound environment at
the cellular and biochemical levels, leading to improved healing of both acute and the chronic wounds.
Examination of wound fluids has the potential to develop into monitoring tools, to serve as markers for certain
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critical events in the tissues, and subsequently offer diagnostic and prognostic information as well as offer an
opportunity to more effectively evaluate wound healing therapies. For example, in a study evaluating wound
fluid from 47 patients who had undergone mastectomy, one group found that surgical wounds that later
developed an infection (11%) had significantly lower PDGF and ECGF on post-operative day 1 than the noninfected wounds (p < 0.05) . They also found that 62% of the patients who developed a seroma had
significantly lower levels of bFGF than those patients who did not develop a seroma (p < 0.05) (Baker,
Kumar, Melling, Whetter & Leaper, 2008). Tarlton, Vickery, Leaper and Baily (1997) found that a decline in
MMP-9 levels between 24 to 48 hours post-op was a predictor of infection. In another study, Chow, Loo,
Yuen and Cheng found that high levels of IL-4 in wound fluid on post-operative day 1 or high levels of IL-6
on post-operative day 2 in women who had undergone mastectomy was associated with risk of flap necrosis.
The goal of this pilot study project is to examine the relationships among pre- and post-operative
psychological stress experienced by women who are undergoing mastectomy with immediate reconstruction
and wound healing, specifically the chemical mediators of wound healing in the local wound environment.
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VIII. PRELIMINARY PROGRESS/DATA REPORT
If available.

A feasibility study was successfully conducted with 5 subjects to evaluate feasibility of the project and to refine the
process of consent, participant enrollment, data collection and analysis. Subjects were willing to enroll and participate
fully and showed great interest in the project. There was 100% return rate on psychological measures was observed in
the feasibility study. Each of the psychological measures obtained showed an appropriate level of variability thus
appeared promising in regard to their ability to correlate with biological measures. Wound fluid was easily obtainable,
transported and stored. There were no problems associated with retrieving adequate volume for the 27 Bioplex analysis.
Trends in cytokines were detected and were supported by the research reported above. For example, the plot of IL-6
(see figure 1) illustrates a rapid rise from time 1 (24 hours) to time 2 (48 hours) and finally back to time 1 levels at time
4 (72 hours). Interesting trends were observed in nearly all the cytokines. However, IL-6 was chosen as a surrogate for
the other 26 cytokines because IL-6 is most commonly cited in the literature. The trends seen in the feasibility data
support our hypothesis and thus indicate the need for further study with a larger sample size.
Figure 1
Fit Y by X Group
Oneway Analysis of IL-2 By Coll. Time
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IX. RESEARCH METHOD AND DESIGN
Include a brief description of the project design including the setting in which the research will be conducted and
procedures. If applicable, include a description of procedures being performed already for diagnostic or treatment
purposes.

This pilot study will prospectively evaluate 20 women with breast cancer who are having total or
modified radical mastectomies with immediate or delayed reconstruction with autologous abdominal tissue.
Although our sample size is small, previous studies (Takamiya, Fujita, Saigusa & Aoki, 2007) have
demonstrated that meaningful cytokine patterns can be found with a sample as small as 5. Data collected will
include demographics, cancer type and stage, length of surgery, intra-operative complications, medical comorbidities and medications, pain levels and pain medications used, and previous treatment with
chemotherapy.
Methods
After obtaining informed consent the following procedures will be used to obtain study data:
Patients usually come to the clinic approximately 7-10 days before their scheduled surgery for a
preoperative history and physical exam. The stress questionnaires will be administered at that time. The 10item Perceived Stress Scale (PSS) (Cohen, Kamarck, & Mermelstein, 1983), 100mm Visual Analog Scale
measuring stress, and the 22-item Impact of Events Scale-Revised (Creamer, Bell & Failla, 2003) will be
administered at that time to evaluate preoperative perceived stress levels. Two cc (about 1 tsp) of blood will be
collected in concert with pre-operative blood work to evaluate peripheral blood cytokines.
Wound fluid, collected by the student investigator, will be removed from the tubing of the JacksonPratt drain, which is already in place post-operatively and is a routine method for post-operative serous fluid
management in the surgical site. Fluid will be collected at 24, 48, 72, and 96 hours post-operatively from the
Jackson-Pratt tubing and stored at -70 C in the VCU Center for Biobehavioral Clinical Research until samples
have been collected from all participants. At the 48-hour collection, an additional IES-R and the stress visual
analog scale will be administered to the patient. If the patient is too tired or sedated to read the form, the
student investigator will read the form and record answers for the study subject. An additional 2 cc of blood
will be collected for peripheral blood cytokine analysis at this time as well.
Levels of cytokines in the wound fluid and blood will be determined using a Bio-Plex Magnetic Bead
Array System (Bio-Rad®) with the 27-plex cytokine detection kit according to the kit manufacturer’s protocol.
Assays will be performed in the VCU School of Nursing CBCR laboratory; we have extensive experience with
measurement of analytes from human samples. The Bio-Plex assay combines fluorescent flow cytometry and
ELISA technology, providing simultaneous quantitation of each of the 27 cytokines using an analyte quantity
as small as 12 µl. The manufacturer reports that the assay accurately measures cytokine values in the range of
1-2,500 pg/ml (well within the limits of detection for this project), is precise (intra-assay CV < 10%, interDecember, 8, 2010
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assay CV < 15%), and shows less than 1% cross-reactivity among cytokines or with other molecules.
Demographics, medications and comorbidities will be recorded at pre-op visit; comorbidities and
cancer type/stage verified postoperatively. The student researcher will directly ask the patient to rate her pain
at the time of each fluid collection. Pain will be rated on scale of 0-10, with 0 being no pain and 10 being the
worst pain. Subjects will be followed weekly to biweekly as part of their routine post surgical care. Surgical
complications such as the development of seroma, flap necrosis or infection, will be followed during this time
and will be documented if they occur. Additionally, we will monitor total length of time the drains were
present.

X. PLAN FOR CONTROL OF INVESTIGATIONAL DRUGS, BIOLOGICS, AND DEVICES.

For investigational drugs and biologics: IF IDS is not being used, attach the IDS confirmation of receipt of the
management plan.. See item #11 on Initial Review form.
For investigational and humanitarian use devices (HUDs): Describe your plans for the control of investigational
devices and HUDs including: (1) how you will maintain records of the product’s delivery to the trial site, the
inventory at the site, the use by each subject, and the return to the sponsor or alternative disposition of unused
product(s); (2) plan for storing the investigational product(s)/ HUD as specified by the sponsor (if any) and in
accordance with applicable regulatory requirements; (3) plan for ensuring that the investigational product(s)/HUDs
are used only in accordance with the approved protocol; and (4) how you will ensure that each subject understands
the correct use of the investigational product(s)/HUDs (if applicable) and check that each subject is following the
instructions properly (on an ongoing basis).
N/A
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XI. DATA ANALYSIS PLAN
For investigator–initiated studies.

All demographic data will be summarized using descriptive statistics (i.e. means and variance for
continuous data and frequencies for the categorical data). Using profile plots (commonly referred to as
spaghetti plots), the biologic data will be illustrated over time both within and across the cytokines. These
plots will be visually examined for similarities. It is anticipated that the observed trends will suggest groupings
of the cytokines and, as a consequence, suggest ways of reducing the dimensionality of the data (e.g., the
development of a composite score using the factor loading from factor analysis).
The levels of perceived stress will be examined descriptively with the intention of detecting associative
trends with the biologic data. We will also look for correspondence of peripheral blood cytokines and wound
fluid cytokines using the Pearson’s correlation and examine correlations between pre- and post-operative stress
and peripheral blood and wound fluid cytokines. It has been the experience of the investigators that the
cytokine data are not normally distributed. Thus, it is anticipated that the log transformed cytokines will be
used for calculation of the correlations.

XII. DATA AND SAFETY MONITORING
 If the research involves greater than minimal risk and there is no provision made for data and safety monitoring
by any sponsor, include a data and safety-monitoring plan that is suitable for the level of risk to be faced by
subjects and the nature of the research involved.
 If the research involves greater than minimal risk, and there is a provision made for data and safety monitoring
by any sponsor, describe the sponsor’s plan.
 If you are serving as a Sponsor-Investigator, identify the Contract Research Organization (CRO) that you will
be using and describe the provisions made for data and safety monitoring by the CRO. Guidance on additional
requirements for Sponsor-Investigators is available at
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#X-2.htm

The pilot study involves the administration of two questionnaires, stress rating on a visual analog scale,
collection of fluid from drains previously inserted for medical purposes, and the collection of blood. The study
involves no intervention and no interference with the placement of the drain. The first peripheral blood draw
will take place at the time of preoperative blood work. The second peripheral blood draw will be performed by
the student researcher who is a licensed nurse practitioner and is fully trained in venipunture procedures.
The investigators will be the only individuals allowed to review the data with patient identifiers in
place. Each subject will be assigned a study number, which will be the only link to identifying information. No
identifying information will be entered into the electronic database. The master list of patient names, medical
record numbers and study numbers will be kept in a secure place and destroyed after the data collection is
December, 8, 2010
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completed.

XIII. MULTI-CENTER STUDIES
If VCU is the lead site in a multi-center project or the VCU PI is the lead investigator in a multi-center project,
describe the plan for management of information that may be relevant to the protection of subjects, such as
reporting of unexpected problems, project modifications, and interim results.

N/A

XIV. INVOLVEMENT OF NON-VCU INSTITUTIONS/SITES (DOMESTIC AND FOREIGN)
1. Provide the following information for each non-VCU institution/site (domestic and foreign) that has agreed to
participate:
 Name of institution/site
 Contact information for institution/site

N/A

2. For each institution, indicate whether or not it is “engaged” in the research (see OHRP’s guidance on
“Engagement of
Institutions in Research” at http://www.hhs.gov/ohrp/humansubjects/assurance/engage.htm.)

N/A

3. Provide a description of each institution’s role (whether engaged or not) in the human subjects research, adequacy
of the facility (in order to ensure human subject safety in the case of an unanticipated emergency), responsibilities of
its agents/employees, and oversight that you will be providing in order to ensure adequate and ongoing protection of
the human subjects. You should only identify institutions that have agreed to participate. If additional institutions
agree to participate at a later time, they must be added by amendment to the protocol.

N/A
4. For each institution that is “engaged” provide an OHRP Federalwide Assurance (FWA) # if: (1) the research is not
exempt, AND (2) the research involves a DIRECT FEDERAL award made to VCU (or application for such).
NOTE: Additional guidance at http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-6.htm, and
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-11.htm.

N/A

XV. INVOLVEMENT OF INDEPENDENT INVESTIGATORS
INDEPENDENT INVESTIGATOR: an individual who is acting independently and not acting as an agent or employee of
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any institution or facility while carrying out his or her duties in the research protocol. Additional guidance at
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-15.htm.
ENGAGEMENT IN RESEARCH: An independent investigator becomes "engaged" in human subjects research when
he/she (i) intervenes or interacts with living individuals for research purposes; or (ii) obtains individually identifiable
private information for research purposes [45 CFR 46.102(d)-(f)]. See OHRP’s guidance on “Engagement of
Institutions in Research” at http://www.hhs.gov/ohrp/humansubjects/assurance/engage.htm.
1. Provide a list of independent investigators.
2. For each independent investigator indicate whether or not he/she is “engaged” or “not engaged” in the research
3. For each independent investigator who is “engaged”: (1) describe his/her role with human subjects/identifiable
human data, AND (2) describe YOUR oversight of his/her involvement.
N/A
NOTE: If an independent investigator is “engaged,” and the research is (1) not exempt AND (2) involves a DIRECT FEDERAL
award made to VCU (or application for such), the independent investigator must sign a formal written agreement with VCU
certifying terms for the protection of human subjects. For an agreement to be approved: (1) the PI must directly supervise all
of the research activities, (2) agreement must follow the ORSP template, (3) IRB must agree to the involvement of the
independent investigator, AND (4) agreement must be in effect prior to final IRB approval.
XVI. HUMAN SUBJECTS INSTRUCTIONS (Be sure to use the sub-headings under A-I)
ALL sections of the Human Subjects Instructions must be completed with the exception of the section entitled
“Special Consent Provisions.” Complete that section if applicable.
A. DESCRIPTION
Provide a detailed description of the proposed involvement of human subjects or their private identifiable data in the
work.

A convenience sample of 20 women with breast cancer, age 21-65, who will be having immediate or delayed
reconstruction after their total or modified radical mastectomy with an abdominally based autologous tissue will
be recruited for this study. Following explanation of the study and fully informed, documented consent,
participants will be enrolled and demographic information will be collected. Participants will be asked to
complete the 10-item Perceived Stress Scale (PSS), the Impact of Event Scale Revised (IES-R) and a visual
stress an . During this visit, patients are usually sent to the lab to have their pre-operative blood work drawn. An
additional tube of blood will be collected for our research to analyze peripheral cytokines. Approximately 24
hours after their surgery, the second Perceived Stress Scale will be administered. If the study participant is too
weak or sedated to read the survey, then the student researcher will read the questionnaire. At this time, the
student researcher will also be obtaining a second blood draw.

B. SUBJECT POPULATION
Describe the subject population in terms of sex, race, ethnicity, age, etc., and your access to the population that will
allow recruitment of the necessary number of participants. Identify the criteria for inclusion or exclusion of any
subpopulation and include a justification for any exclusion. Explain the rationale for the involvement of special cases
of subjects, such as children, pregnant women, human fetuses, neonates, prisoners or others who are likely to be
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vulnerable. If you plan to allow for the enrollment of Wards of the State (or any other agency, institution, or entity),
you must specifically request their inclusion and follow guidance on Wards and Emancipated Minors in the VCU IRB
Written Policies and Procedures (specifically WPP#: XV-3) available at
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XV-3.htm.

The target population will be women referred to the VCUHS Plastic and Reconstructive Surgery practice
for breast reconstruction following total or modified radical mastectomy for a diagnosis of breast cancer. All
women who are considering autologous abdominal tissue reconstruction will be potential candidates in
accordance with the study inclusion and exclusion criteria. Prisoners will be excluded, as their circumstances
involving transportation may be extenuating.
For consideration of an autologous abdominal tissue reconstruction, a multitude of factors are taken into
consideration to identify suitable appropriate surgical candidates. The length and complexity of these
reconstructive surgical procedures requires that patients be evaluated based on risk factors proposed by
Hartrampf (1991) which include psychological stability, diabetes, vascular disease, healthy weight, smoking
history, past abdominal surgeries, pulmonary disease and cardiac disease. Essentially, women who are
considered good surgical candidates and selected by the surgeon for the procedure are in good health other than
their cancer diagnosis.
Inclusion criteria for this pilot study will include females aged 21 – 65, who have been diagnosed with
breast cancer and are undergoing autologous abdominal tissue reconstruction following their mastectomies.
Exclusion criteria include
1.

Patients on immunosuppressive medications and those women who have had a hysterectomy or
oophorectomy or will be undergoing hysterectomy and/or oophorectomy at the time of mastectomy.
We have excluded these participants to control hormonal effects this type of surgery may cause.

2.

Pregnancy

3.

Past medical history of autoimmune disorders

We plan to enroll 20 participants. Enrollment will occur through convenience sampling using the above
criteria. Study sampling will not interfere with required and scheduled care of the participant. Participants may
withdraw from the study at any time. This will not impact the care of the participant in any way.
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C. RESEARCH MATERIAL
Identify the sources of research material obtained from individually identifiable living human subjects in the form of
specimens, records, or data. Indicate whether the material or data will be obtained specifically for research purposes
or whether use will be made of existing specimens, records, or data.

Research material includes wound fluid samples that would otherwise be discarded, blood samples,
demographic information, information regarding immediate operative and post-operative course, and
information obtained from the stress questionnaires and analog scales. These materials will be obtained for
research purposes only.

D. RECRUITMENT PLAN
Describe in detail your plans for the recruitment of subjects including: (1) how potential subjects will be identified
(e.g., school personnel, health care professionals, etc), (2) how you will get the names and contact information for
potential subjects, and (3) who will make initial contact with these individuals (if relevant) and how that contact will
be done. If you plan to involve special cases of subjects, such as children, pregnant women, human fetuses, neonates,
prisoners or others who are likely to be vulnerable, describe any special recruitment procedures for these populations.

Following IRB approval, subjects will be recruited prospectively as they present to the Plastic and
Reconstructive Surgery department for their pre-operative appointment. These patients will have already had
their first consultation with the plastic surgeon and the type of reconstruction will have already been decided
upon and scheduled. The plastic surgeons will offer the patient the opportunity to participate in this pilot study
and then the study staff will approach the patient if the patient is interested in participating.

E. POTENTIAL RISKS
Describe potential risks whether physical, psychological, social, legal, or other and assess their likelihood and
seriousness. Where appropriate, describe alternative treatments and procedures that might be advantageous to the
subjects.

This pilot study presents no more than minimal risk to the study participants. Participants may be
inconvenienced by providing demographic information or completing the second PSS. Risks associated with
venipuncture include mild pain and/or bruising at the site. Another potential risk to the subjects is breech of
confidentiality.
F. RISK REDUCTION
Describe the procedures for protecting against or minimizing potential risk. Where appropriate, discuss provisions
for ensuring necessary medical or professional intervention in the event of adverse events to the subjects. Also, where
appropriate, describe the provisions for monitoring the data collected to ensure the safety of subjects.
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This pilot study presents no more than minimal risk to study participants. Written informed consent will
be required for enrollment and participation in this study. The student investigator will review the study fully
with potential participants and answer any questions they may have.
Access to wound fluid will be through a Jackson-Pratt drain, which is standard of care in these patients.
The drain will not be kept in longer than medically necessary, as decided by the plastic surgeon who performed
the surgery. Therefore, risk associated with collection of drain fluid is minimal.
Risk associated with venipuncture is reduced by collecting the first blood sample during routine blood
work evaluation and by use of sterile procedures and universal precautions when the experienced, student
researcher draws the second, post-operative blood sample.
A potential risk to the subjects is breech of confidentiality. In order to minimize such risk, each subject
will be assigned a study number, and no other identifying information will be recorded. A master list of medical
record numbers and study numbers will be available only to study staff for purposes of chart identification and
will be kept in a secure, locked file cabinet when not in use. Once all of the data have been collected, this master
list will be destroyed.

G. ADDITIONAL SAFEGUARDS IF ANY PARTICIPANTS WILL BE VULNERABLE
Describe any additional safeguards to protect the rights and welfare of participants if you plan to involve special cases
of subjects, such as children, pregnant women, human fetuses, neonates, prisoners or others who are likely to be
vulnerable. Safeguards to protect the rights and welfare of participants might relate to Inclusion/Exclusion Criteria:
(“Adults with moderate to severe cognitive impairment will be excluded.” “Children must have diabetes. No normal
controls who are children will be used.”) Consent: (“Participants must have an adult care giver who agrees to the
participant taking part in the research and will make sure the participant complies with research procedures.”
“Adults must be able to assent. Any dissent by the participant will end the research procedures.”) Benefit:
(“Individuals who have not shown benefit to this type of drug in the past will be excluded.”).

N/A

H. CONFIDENTIALITY
Describe how the confidentiality of data collected as part of this project will be protected including pre-screening data
(e.g., physical controls on the data; access controls to the data; coding of data; legal controls, such as a Federal
Certificate of Confidentiality; statistical methods; or reporting methods).
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The investigators will be the only individuals allowed to review the data with patient identifiers in place. All
data will be maintained by the student investigator and identities protected. Unidentifiable coding procedures
consist of each subject being assigned a study number, which will be the only identifying information collected
and recorded in the electronic database. The master list of patient names, medical record numbers and study
numbers will be kept in a secure place and destroyed after the data collection is completed. All survey and
laboratory data will be coded.

I. PRIVACY
Describe how the privacy interests of subjects will be protected where privacy refers to persons and their interests in
controlling access to themselves, and assess their likely effectiveness. Identify what steps you will take for subjects to
be comfortable: (1) in the research setting and (2) with the information being sought and the way it is sought.

Study participants will be given time to complete surveys in a private setting. The investigators will be the only
individual allowed to review the data with patient identifiers in place. Each subject will be assigned a study
number, which will be the only identifying information collected and recorded in the electronic database. The
master list of patient names, medical record numbers and study numbers will be kept in a secure place and
destroyed after the data collection is completed.

J. RISK/BENEFIT
Discuss why the risks to subjects are reasonable in relation to the anticipated benefits to subjects and in relation to the
importance of the knowledge that may reasonably be expected to result. If a test article (investigational new drug,
device, or biologic) is involved, name the test article and supply the FDA approval letter.

There is no direct benefit to the participant although there is potential for future benefit to others. Risk to the
participant is minimal. The wound fluid of interest will be withdrawn through a drain previously placed for
medical purposes; this fluid is usually measured for volume and immediately discarded. Once data are
collected, all personal identifying information will be destroyed.

K. COMPENSATION PLAN
Compensation for subjects (if applicable) should be described, including possible total compensation, any proposed
bonus, and any proposed reductions or penalties for not completing the project.

No compensation will be offered.
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L. CONSENT ISSUES
1. CONSENT PROCESS
Indicate who will be asked to provide consent/assent, who will obtain consent/assent, what language (e.g., English,
Spanish) will be used by those obtaining consent/assent, where and when will consent/assent be obtained, what steps
will be taken to minimize the possibility of coercion or undue influence, and how much time will subjects be afforded
to make a decision to participate.

Following IRB approval and prior to any data collection, documented informed consent will be obtained by the
student investigator only from those patients who agree to be in the study. Patients will not be approached by
the investigator until the surgeon has discussed the study with the patient. If the patient agrees to learn more
about the study, then the investigator will review the consent information with the patient and answer any
questions. Ideally, this first step will occur at the consultation visit, if at that time an autologous abdominal
tissue reconstruction is decided upon. If the potential participant needs more time, she may take the consent
information home and call the PI or student investigator with any questions or concerns. Fully informed consent
will be obtained prior to surgery, either at the consultation visit or the pre-operative visit. No additional travel
will be required above what is required for routine medical care.

2. SPECIAL CONSENT PROVISIONS
If some or all subjects will be cognitively impaired, or have language/hearing difficulties, describe how capacity for
consent will be determined. Please consider using the VCU Informed Consent Evaluation Instrument available at
http://www.research.vcu.edu/irb/guidance.htm. If you anticipate the need to obtain informed consent from legally
authorized representatives (LARs), please describe how you will identify an appropriate representative and ensure
that their consent is obtained. Guidance on LAR is available at
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XI-3.htm.

N/A

3. If request is being made to WAIVE SOME OR ALL ELEMENTS OF INFORMED CONSENT FROM SUBJECTS OR
PERMISSION FROM PARENTS, explain why: (1) the research involves no more than minimal risk to the subjects, (2) the
waiver or alteration will not adversely affect the rights and welfare of the subjects, (3) the research could not
practicably be carried out without the waiver or alteration; AND (4) whether or not subjects will be debriefed after
their participation. Guidance is available at http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XI-1.htm..
NOTE: Waiver is not allowed for FDA-regulated research unless it meets FDA requirements for Waiver of Consent
for Emergency Research (see below).
N/A
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4. If request is being made to WAIVE DOCUMENTATION OF CONSENT, provide a justification for waiver based on one of
the following two elements AND include a description of the information that will be provided to participants: (1) the
only record linking the subject and the research would be the consent document and the principal risk would be
potential harm resulting from a breach of confidentiality. Subject will be asked whether they want documentation
linking them with the research, and each subject’s wishes will govern; or (2) the research presents no more than
minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of
the research context. Guidance is available at http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XI-2.htm

N/A

5. If applicable, explain the ASSENT PROCESS for children or decisionally impaired subjects. Describe the
procedures, if any, for re-consenting children upon attainment of adulthood. Describe procedures, if any, for
consenting subjects who are no longer decisionally impaired. Guidance is available at
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XV-2.htm.and
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-7.htm.

N/A

6. If request is being made to WAIVE THE REQUIREMENT TO OBTAIN ASSENT from children age 7 or higher, or
decisionally impaired subjects, explain why: (1) why some or all of the individuals age 7 or higher will not be capable
of providing assent based on their developmental status or impact of illness; (2) the research holds out a prospect of
direct benefit not available outside of the research; AND/OR (3) [a] the research involves no more than minimal risk to
the subjects, [b] the waiver or alteration will not adversely affect the rights and welfare of the subjects, [c] the
research could not practicably be carried out without the waiver or alteration; AND [d] whether or not subjects will be
debriefed after their participation. Guidance is available at
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XV-2.htm

N/A

7. If request is being made to waive consent for emergency research, see guidance at
http://www.research.vcu.edu/irb/wpp/flash/wpp_guide.htm#XVII-16.htm.

N/A

8. If applicable, address the following issues related to GENETIC TESTING:
No genetic testing is involved in this research protocol
a. FUTURE CONTACT CONCERNING FURTHER GENETIC TESTING RESEARCH
Describe the circumstances under which the subject might be contacted in the future concerning further participation
in this or related genetic testing research.
N/A
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b. FUTURE CONTACT CONCERNING GENETIC TESTING RESULTS
If planned or possible future genetic testing results are unlikely to have clinical implications, then a statement that the
results will not be made available to subjects may be appropriate. If results might be of clinical significance, then
describe the circumstances and procedures by which subjects would receive results. Describe how subjects might
access genetic counseling for assistance in understanding the implications of genetic testing results, and whether this
might involve costs to subjects. Investigators should be aware that federal regulations, in general, require that testing
results used in clinical management must have been obtained in a CLIA-certified laboratory.

N/A
c. WITHDRAWAL OF GENETIC TESTING CONSENT
Describe whether and how subjects might, in the future, request to have test results and/or samples withdrawn in
order to prevent further analysis, reporting, and/or testing.

N/A

d. GENETIC TESTING INVOLVING CHILDREN OR DECISIONALLY IMPAIRED SUBJECTS
Describe procedures, if any, for consenting children upon the attainment of adulthood. Describe procedures, if any,
for consenting subjects who are no longer decisionally impaired.

N/A

e. CONFIDENTIALITY
Describe the extent to which genetic testing results will remain confidential and special precautions, if any, to protect
confidentiality.

N/A
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Abstract
This was a pilot study to examine pre- and post-operative stress experienced by women
who were undergoing autologous breast reconstruction and how stress might impact
wound healing, specifically examining cytokines and other the chemical mediators in the
wound environment. A non-experimental descriptive design over time was utilized.
Participants were women who were undergoing autologous abdominal breast
reconstruction for breast cancer (N =20). Data were collected pre-operatively and at 24,
48, 72 and 96 hours post surgery. Complications were monitored intra-operatively and up
to 30 days post surgery. Psychological stress was measured with the 10-item Perceived
Stress Scale (PSS), the Impact of Events Scale-Revised (IES-R), and a 100mm Visual
Analogue Scale (VAS). Cytokines were assayed using the 27-plex kit with a Bio-Plex
Plus®. While breast cancer is considered a stressor, in this sample of women, scores of
the PSS, IES-R and VAS showed that in fact these participants experienced low levels of
psychological stress. All measured biochemical mediators in serum and wound fluid were
detected and trends were identified. IL-1ra, IL-6, IL-8, G-CSF, IP-10, MCP1, MIP-1b,
RANTES and VEGF were present in the highest concentrations. Significant changes in
levels of cytokines in wound fluid were observed in IL-1, IL-2, IL-5, IL-6, IL-8, IL-9,
IL-10, IL-17, FGF-basic, G-CSF, MIP-1a, PDGF-bb, MIP1b, RANTES, and TNF-. The
remaining cytokine concentrations remained stable over time. These findings suggest that
although these women were not experiencing high levels of stress, meaningful cytokine
patterns were detected.
Keywords: psychological stress, wound healing, cytokine, growth factor

33

Perceived Stress and Surgical Wound Cytokine Patterns

3

Introduction
Research has shown a strong relationship between psychological stress and
health. Thought of as a human response to a specific stimulus or “stressor”, stress can
initiate a cascade of events leading to a variety of detrimental effects on health. One such
negative impact is that on wound healing. The mechanism by which stress is thought to
exert negative impact on wound healing is through its effects on cellular immunity,
leading to a disruption of the wound healing process. When normal wound healing is
interrupted, chronic wounds develop, leading to increased risk of infection, increased
hospital stays, and decreased quality of life. Numerous studies have shown that
psychological stress may slow wound healing, but specific mechanisms remain uncertain.
“Analysis of wound fluid provides an opportunity to potentially connect the mechanism
of psychological stress to cellular mechanisms in the local wound site” (Lucas, 2011, p.
80). The purpose of this research was to examine the relationships among pre- and postoperative psychological stress experienced by women who were undergoing autologous
abdominal reconstruction for mastectomy. Specifically, the biochemical mediators of
wound healing in the local wound environment were examined over time.
Background
The Stress Response and Wound Healing
Psychological stress, once experienced by an individual, results in neuroendocrine
signals being transmitted from the brain leading to changes in the immune system.
Cellular immunity has an important role in the regulation of wound healing through the
production and regulation of pro-inflammatory and anti-inflammatory cytokines. Stress
affects neuroendocrine functioning via two pathways, the hypothalamic-pituitary-adrenal
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(HPA) axis of the central nervous system and the sympathetico-adreno-medullary (SAM)
axis of the sympathetic nervous system. When we encounter a stressful event, there is
simultaneous activation of the HPA axis and the SAM axis.
Activation of the SAM axis causes acetylcholine to be secreted from the adrenal
medulla. This leads to release of the catecholamines norepinephrine and epinephrine into
the systemic blood supply. This activation is responsible for the classic “Fight or Flight”
response, such as increased heart rate, increased blood flow to the skeletal muscles, and
increased glucose metabolism. These catecholamines also are responsible for activating
the inflammatory response (Glaser & Kiecolt-Glaser, 2005; Sorrells & Sapolsky, 2007;
Vileikyte, 2007; Yang & Glaser, 2002).
When the HPA system is activated by stress, corticotropin-releasing hormone
(CRH) is released from the hypothalamus. CRH then stimulates the release of
adrenocorticotropic hormone (ACTH) from the anterior pituitary into systemic
circulation, which in turn triggers release of the glucocorticoid cortisol from the adrenal
cortex. Elevated levels of cortisol suppress the immune system in a variety of ways.
Cortisol inhibits the migration of leukocytes to a site of infection by decreasing capillary
permeability and inhibiting chemotaxis. Cortisol has also been shown to stabilize
lysosomal membranes thus inhibiting release of their infection-fighting proteolytic
enzymes. Cortisol decreases fibroblast proliferation and function at the site of injury as
well as inhibits the release of inflammatory substrates such as histamine and
prostaglandins. Importantly, cortisol inhibits production of certain cytokines such as
interleukin (IL)-1 and tumor necrosis factor (TNF) (Boyapati & Wang, 2007; Glaser &
Kiecolt-Glaser, 2005).
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As recently reviewed by Lucas (2011), wound healing is regulated by cellular
processes controlled by the immune system. The complex and orderly process of normal
cutaneous wound healing occurs in overlapping phases and depends upon multiple
interactions among various biochemical mediators and cell types. Successful wound
healing is highly dependent on an orderly progression of the first phase, the inflammatory
phase. Within seconds of injury, the inflammatory phase is initiated and can last
anywhere from 2 to 7 days. Platelets are activated when blood vessels are disrupted and
clotting factors are released. Vasoconstriction and platelet aggregation lead to the
formation of a provisional matrix for cellular migration of neutrophils and macrophages
into the wounded area to begin to remove bacteria from the wound and initiate tissue
repair (Christian, Graham, Padgett, Glaser, & Kiecolt-Glaser, 2006; Doughty & SparksDefries; 2007; Li, Chen, & Kirsner, 2007; Mehendale & Martin, 2001). Inflammatory
mediators such as cytokines play a crucial role in attracting phagocytes to the wound bed
and orchestrating the production and release of growth factors and matrix
metalloproteinase (MMP) enzymes crucial for collagen organization. These early
biochemical mediators also play a role in recruiting cells and growth factors needed later
for tissue regeneration (Monaco & Lawrence, 2003; Singer & Clark, 1999).
Stress and Breast Cancer
According to the American Cancer Society, breast cancer is the most common
malignancy diagnosis in women. In the United States, there were approximately 284,520
new cases of breast cancer in 2011. Approximately 39,520 deaths were attributed to
breast cancer in that same year (American Cancer Society, 2011). In 2010, approximately
93,000 women underwent mastectomy with some form of reconstruction (American
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Society of Plastic Surgeons, 2011). Ananian et al. (2004) showed that 83% of women
choose immediate breast reconstruction following mastectomy. However, Roth, Lowery,
Davis, and Wilkins (2005) documented a relatively higher incidence of psychosocial
impairment and functional disability in women who pursue immediate reconstruction
following mastectomy. Investigators have looked at psychological factors in women with
breast cancer and how such factors impact satisfaction with their reconstruction and
quality of life (Roth et al., 2005), yet little is known about the effects of pre- and postoperative stress associated with mastectomy and reconstruction on the process and
outcomes of wound healing.
Surgical wound complications such as infection, delayed closure, and wound
dehiscence are associated with longer hospital stays, decreased quality of life, and
increases in morbidity and mortality (Zhan & Miller, 2003). Wounds that fail to progress
through the orderly healing process and convert to chronic wounds even more
significantly increase cost of care, decrease quality of life, and lead to increases in
morbidity and mortality (Sen et al., 2009; Shukla et al., 2008).
By regulating chemotaxis and cellular proliferation, cytokines, chemokines, and
growth factors, which for the purpose of this paper will be referred to as biochemical
mediators, are involved in the initiation, control, and termination of the cellular processes
that occur at each phase of wound healing. Each biochemical mediator functions in
various ways, either alone, synergistically with another, or overlapping with another, to
accomplish healing (Baker, El-Gaddal, Aitken, & Leaper, 2003). By understanding the
role of these biochemical mediators in the wound environment, we may better understand
the complex biochemical interactions and mediators of healing in the wound. Given such
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understanding, we may further develop technologies and interventions that impact the
wound environment at the cellular and biochemical levels, leading to improved healing of
both acute and chronic wounds.
Examination of wound fluids has the potential to aid in developing monitoring
tools, to identify markers for certain critical events in the tissues, and subsequently to
offer diagnostic and prognostic information as well as opportunities to more effectively
evaluate wound healing therapies. For example, in a study evaluating wound fluid from
47 patients who had undergone mastectomy, one group found that the 11% of surgical
wounds that later developed an infection had significantly lower concentrations platelet
derived growth factor (PDGF) and endothelial cell growth factor (ECGF) on postoperative day 1 than the non-infected wounds (p < 0.05). They also found that 62% of the
patients who developed a seroma had significantly lower levels of basic fibroblast growth
factor (bFGF) than those patients who did not develop a seroma (p < 0.05) (Baker,
Kumar, Melling, Whetter, & Leaper, 2008). Tarlton, Vickery, Leaper, and Baily (1997)
found that a decline in MMP-9 levels between 24 and 48 hours post-operatively was a
predictor of infection. In another study, Chow, Loo, Yuen and Cheng (2003) found that
high levels of IL-4 in wound fluid on post-operative day 1 or high levels of IL-6 on postoperative day 2 in women who had undergone mastectomy was associated with risk of
reconstructive flap necrosis. These studies illustrate the utility for examining the process
of wound healing using wound fluid in order to advance understanding of the potential
mechanisms and modifying factors that ultimately might be targeted for improving
outcomes.
Theoretical Framework
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An integration of Lazarus and Folkman’s cognitive appraisal model of stress and
coping and the McCain, Gray, Walter, and Robins (2005) model of the
psychoneuroimmunology (PNI) framework guided this study. According to Lazarus and
Folkman (1984), stress is a subjective experience that occurs when a person appraises an
event to be stressful and demands exceed available resources to cope or deal with that
event. This interaction between the environment or stressor and the person who perceives
or appraises the event as stressful is referred to as the transactional model of stress. PNI is
a theoretical perspective that utilizes the transactional model of stress to explore the
complex interactions and relationships between behaviors and the neuroendocrine and
immune systems and the environmental and psychosocial factors that may moderate these
interactions (Caudell, 1996; McCain, Gray, Walter & Robins, 2005, Zeller, McCain &
Swanson, 1996). The PNI model proposed by McCain et al. (2005) provides a framework
to evaluate the complex interactions between behavior and its effects on health and
wellbeing. “The major purpose of PNI research is to determine whether a valid
association exists between risk factors such as stressors, depression or pain and the
outcome” (Zeller, McCain, McCann, Swanson, & Colletti, 1996, p. 314). Evidence
supports the association between psychological stress and immune system functioning
(Sergerstom & Miller, 2004), and cell mediated immunity, including interactions between
various biochemical mediators, plays an important role in the early inflammatory stages
of wound healing. It is through this pathway that stress may impair wound healing, by
attenuating the initial inflammatory phase of the wound healing response and thus
disrupting the orderly progression of normal wound healing (Hubner et al., 1996; Lucas,
2011).
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Research Objectives
The purpose of this study was to first identify patterns of biochemical mediators
present in acute surgical wound fluid over time. Additionally, we wanted to describe the
relationship of psychological stress and the biochemical mediators of wound healing in
the local wound environment.
Method
Design
This study used a descriptive non-experimental design with samples collected
over time to describe biochemical patterns (including selected cytokines, chemokines,
and growth factors) in surgical wounds in women undergoing breast reconstruction at a
southeastern United States urban academic medical center. Following institutional board
review approval, participants were recruited from the plastic and reconstructive surgery
office over a 38-month time period.
Participants
The target population was women referred to the Virginia Commonwealth
University (VCU) Plastic and Reconstructive Surgery practice for autologous breast
reconstruction following mastectomy for a diagnosis of breast cancer. This convenience
sample was recruited prospectively as they presented to the practice for their preoperative visits. This visit followed the consultation visit with the plastic surgeon and the
type of reconstruction had been determined prior to the pre-operative research enrollment
visit.
From this target population, 20 English-speaking women aged 21-65 with breast
cancer or a history of breast cancer and who were scheduled to have abdominally based
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autologous tissue reconstruction were enrolled in the study. For consideration of
autologous abdominal tissue reconstruction, a multitude of factors are taken into
consideration to identify appropriate surgical candidates. The length and complexity of
these reconstructive surgical procedures require that patients be evaluated based on risk
factors proposed by Hartrampf (1991), which include psychological stability, diabetes,
vascular disease, weight, smoking history, past abdominal surgeries, pulmonary disease
and cardiac disease. Essentially, women who are considered good surgical candidates and
selected by the surgeon for the procedure are in good health except for their cancer
diagnosis. Also excluded from the study were patients on immunosuppressive
medications, women undergoing hysterectomy and/or oophorectomy at the time of
mastectomy, women who were pregnant or women with a medical history of autoimmune
disorders. Autologous breast reconstruction provides a good model for studying acute
wound healing because the abdominal incision is a clean wound uncomplicated by the
biological factors and treatment-related factors associated with breast cancer, such as
radiation. The resulting abdominal wound has a large surface area that drains easily with
conventional Jackson-Pratt drains.
Procedure
After full discussion of the study, documented informed consent was obtained.
Data collected included demographic information, cancer type, dates of surgeries,
menstrual cycle data, relevant past surgical history, and chemotherapy and radiation
history. Patients usually came to the clinic approximately 7-10 days before their
scheduled surgery for a pre-operative history and physical examination. The perceived
stress questionnaires were administered at that time. The 10-item Perceived Stress Scale
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(PSS) (Cohen, Kamarck, & Mermelstein, 1983), 100mm Visual Analog Scale (VAS)
measuring stress, and the 22-item Impact of Events Scale-Revised (IES-R) (Creamer,
Bell, & Failla, 2003) were administered to evaluate pre-operative perceived stress levels.
Approximately 2 ml of whole blood was collected in concert with other pre-operative
blood work in order to evaluate peripheral blood levels of the same biochemical
mediators measured in the wound fluid.
Following a participant’s reconstructive surgery, wound fluid from the abdominal
surgical site was obtained from the tubing of the Jackson-Pratt drain routinely placed in
the surgical site during surgery for post-operative serous fluid management. Fluid was
collected from the wound at 24, 48, 72, and 96 hours post-operatively, and immediately
processed and stored at -70 C in the VCU Center for Biobehavioral Clinical Research
(CBCR) until all samples had been collected from all participants. Pain was assessed at
each sample collection point, along with type of pain management being instituted. Pain
was rated on a scale of 0-10, with 0 being no pain and 10 being the worst pain. At the
48-hour collection, the IES-R and the stress VAS were re-administered and an additional
blood sample was collected for peripheral blood analysis of the targeted biochemical
mediators at this time.
Following hospital discharge, participants were followed weekly to biweekly as
part of their routine post-surgical care. Surgical complications such as the development of
seroma, flap necrosis, or infection, were evaluated during this time and were documented
if they occurred.
Measurement of Biochemical Mediators
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Levels of selected cytokines, chemokines, and growth factors in the wound fluid
and plasma were determined using a Bio-Plex Plus® magnetic bead array system
(BioRad, Inc.) with the 27-plex standardized detection kit according to the kit
manufacturer’s protocol. Assays were performed in the VCU School of Nursing Center
for Biobehavioral Clinical Research laboratory. The Bio-Plex assay combines fluorescent
flow cytometry and ELISA technology, providing simultaneous quantitation of each of
the 27 analytes using an analyte quantity as small as 12 µl. The manufacturer reports that
the assay accurately measures analyte values in the range of 1-2,500 pg/ml (well within
the limits of detection for this project), is precise (intra-assay CV < 10%, inter-assay CV
< 15%), and shows less than 1% cross-reactivity among cytokines or with other
molecules. The biochemical mediators detected by this standardized 27-plex kit are
summarized in Appendix 1.
Questionnaires and Scales
Stress was first measured by administration of the 10-item PSS (Cohen, Kamarck,
& Mermelstein, 1983). The PSS was developed based on Lazarus and Folkman’s
transactional model of stress and was intended to evaluate the degree to which
respondents perceived their lives to be unpredictable, uncontrollable, and overloaded
(Cohen et al., 1983; Monroe, 2007). This questionnaire consists of 5 negatively formatted
and 5 positively formatted questions that address nonspecific appraised stress during the
month prior to completing the questionnaire (Cohen et al., 1983). The PSS was
administered at the pre-operative visit.
A VAS is designed to measure the intensity, strength, or magnitude of
individuals’ sensations and subjective feelings and opinions about a specific stimulus
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(Waltz, Strickland & Lenz, 2005). For this study, a 100 mm VAS was completed by
participants before surgery at their pre-operative visit and at 48 hours post-operatively.
Participants were instructed to mark the line after being asked the question, “How much
do you feel stressed right now?” The farthest left point is marked 0 or “not at all”, the
farthest right point is marked 10 or “extremely.”
The IES-R (Weiss & Marmar, 1997) is a widely used self-report measure for
subjective distress related to any traumatic life event. There are 22 items divided into 3
subscales, intrusion, avoidance, and hyperarousal. The scale asks about certain events and
their frequency of occurrence over the past week. Participants are asked to rate each item
in the IES-R on a scale of 0 (not at all), 1 (a little bit), 2 (moderately), 3(quite a bit), or 4
(extremely). A total score of 33 or a average score over 1.5 or higher indicates powerful
impact or traumatic stress levels (Zhang, Y & Ho, 2011). Scores higher than 44 indicate
severe impact and may adversely affect functioning (Meisel et al., 2012). This scale was
administered with the stress VAS at baseline and again at 48 hours post-operatively.
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Data Analysis

Statistical analysis was performed using JMP software, version 12. All
demographic data were summarized using descriptive statistics (i.e., means and
variance for continuous data and frequencies for the categorical data). Biological
data were log10 transformed for statistical manipulation and statistical analysis was
carried out using mixed model analysis to show trends among cytokines over time.
Subject was the fixed effect, level of cytokine was the random effect. Using
profile plots, the biological data were displayed over time both within and across
the biochemical mediators. These plots were visually examined for patterns.
Levels of perceived stress were examined descriptively with the intention of
detecting associative trends with the biological data. Correspondence of peripheral blood
and wound fluid mediators were determined using the Pearson’s correlation. A p-value
of ≤ 0.05 was considered to be statistically significant.
Findings
A total of 20 autologous breast reconstruction patients were enrolled in the study
between September 30, 2008 and December 15, 2011. The age range participants was 3863 years with a mean (+ standard deviation [SD]) of 50.2 (+ 8.2). The BMI range was
19.3-31.8 with a mean of 26.3 (+ 3.5). The majority of participants (70%) were white; all
others were black. Overall, these patients were healthy with few reported comorbidities,
including depression (30%) and hypertension (15%). All participants were postmenopausal, either reporting not having a period in the past year or that they had
undergone hysterectomy at some time prior to their reconstruction (70%).
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Participants undergoing immediate versus delayed reconstruction were equally
divided; the type of reconstruction is summarized in Table 1. Among the 10 participants
who underwent delayed reconstruction, 4 had a history of failed tissue expander
reconstruction in the past, and 8 had a previous history of radiation. Three of the 10
patients who had immediate reconstruction had a history of radiation following segmental
mastectomy for their cancer diagnosis. Cancer type and treatment also are summarized in
Table 1.
Table 1
Cancer Type and Previous Treatment
Timing of Reconstruction
Cancer Type

Delayed

Immediate

DCIS

1

3

DCIS & IDC

0

1

IDC

5

6

ILC

2

0

Inflammatory

2

0

No

2

7

Yes

8

3

History of Radiation

Note: Delayed Reconstruction take place after the reconstruction, Immediate reconstruction takes place
immediately following the mastectomy. DCIS = ductal carcinoma in situ; IDC = infiltrating ductal carcinoma; ILC
= invasive lobular carcinoma

Intraoperative complications occurred in 4 of the 20 participants. Flap failure
subsequently occurred in 2 of these 4 participants. Two participants required
intraoperative blood transfusions.
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In the immediate post-operative phase, 2 participants suffered migraine headaches
and one developed post-operative hypertension, which delayed her discharge by 2 days.
One participant developed a hematoma and another developed an arterial thrombosis in
the reconstructive site; both returned to the operative suite and both reconstructions were
successfully salvaged. One participant developed a large pulmonary saddle embolus
which required surgical intervention and the implementation of anticoagulants, which
caused extensive bleeding from the surgical sites and lead to multiple blood transfusions.
Her data set was incomplete. However, her data collected prior to this significant
complication was included in the data analysis.
Three of the 20 participants developed post-discharge complications. Two women
experienced some distal tip necrosis of the transferred flap, which went on to heal
without complications. Another developed cellulitis upon discharge and was readmitted
for antibiotic therapy and had no further complications.
Psychometric Measures of Stress
In this study, we found low levels of stress preoperatively. All psychometric stress
measures showed a significant positive correlation (p <0.05) and are presented in table 3.
Pre-operatively, participants were asked to complete the PSS, IES-R, and the VAS. The
mean score for the pre-operative PSS was 19.6, with a median of 20.5 and a standard
error of 1.86; scores ranged from 3 to 37. Pre-operative IES-R scores also indicated that
stress levels were low at this time point. Mean IES scores were 1.26, with a median of
1.32 and a standard error of 0.18; scores ranged from 0.8 to 3.04. VAS scores indicated a
slightly higher stress level, but still not severe. Preoperatively, the mean score on the
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VAS was 52.66 with a median score of 48.98, standard error of 7.45, and a range of 2.02
to 100.
Stress scores did not vary much over time. Post-operative stress scales were
administered 48 hours post-surgery. Post-operative IES median scores were 1.4, with a
median score of 1.27, a standard error of 0.19, and a range from 0.20 to 2.71. Postoperative VAS scores were 47.14 with a median score of 49.25, standard error of 7.99,
and a range from 2.04 to 100. Table 2 displays the high intercorrelations among all
psychological stress measures.
Table 2
Pearson’s Correlations for Stress Measures
Time
24 Hours

48 Hours

Stress Measure

Stress Measure

IES

N

Correlation

PSS

20

0.5985*

IES

VAS

15

0.6008*

PSS

VAS

15

0.7152*

IES

VAS

14

0.6945*

Note: IES = Impact of Events Scale; PSS = Perceived Stress Scale; VAS = 100mm Visual Analog Scale

Wound Fluid Biochemical Profiles
All the selected biochemical mediators were detected at some level in the
wound fluid, although some percentages of detection were quite low. In particular,
eotaxin and IL‐15 levels were detected less than 30% of the time. Differential levels
of measured wound fluid mediators were observed for each post‐operative day and
are summarized in Table 3.
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Table 3
Wound Fluid Cytokine Concentrations (pg/ml) Over Time

24 Hours Post‐Op

48 Hours Post‐Op

72 Hours Post‐Op

96 Hours Post‐Op

% Above
Detection

Median

Min, Max

% Above
Detection

Median

Min, Max

% Above
Detection

(4.36,
217.48)

100

13.49

(1.66, 69.40)

100

13.56

(2.39, 47.00)

100

4637.15

(1395.93,
11087.80)

100

4916.57

(209.10,
10024.5)

100

4915.02

(1008.52,
9700.22)

100

75

0.10

(0.10, 9.82)

45

0.10

(0.10, 11.55)

17

0.10

(0.10, 8.47)

30

(1.19, 4.90)

100

1.89

(0.40, 8.75)

100

1.58

(0.03, 3.36)

95

1.71

(0.18, 2.95)

100

3.63

(1.87, 50.80

100

7.52

(1.67,
224.60)

100

10.99

(2.35,
222.37)

100

13.23

(7.03,
262.94)

100

IL‐6

56489.28

(18587.81,
257225.73)

100

28656.34

(2734.93,
91394.87)

100

9073.22

(1353.13,
144174.28)

100

5260.72

(1956.74,
19953.05)

100

IL‐7

20.31

(8.59,
101.23)

100

19.11

(8.29,
102.84)

100

18.47

(6.58, 30.64)

100

21.76

(9.31, 55.30)

100

IL‐8

4452.19

(828.01,
14920.91)

100

2556.82

(583.04,
9841.64)

100

1815.20

(174.01,
9910.90)

100

3026.84

(433.97,
20433.57)

100

IL‐9

20.45

(0.10,
10728.23)

95

13.95

(0.10,
1760.89)

85

7.59

(0.10,
348.87)

78

7.73

(0.10,
359.11)

50

IL‐10

119.56

(34.60,
301.34)

100

75.38

(18.05,
159.53)

100

44.67

(3.84, 95.18)

100

54.04

(15.40,
98.58)

100

IL‐12

262.00

(65.73,
454.11)

100

244.32

(80.23,
450.73)

100

223.88

(14.34,
534.52)

100

262.97

(71.99,
503.50)

100

IL‐13

88.77

(46.47,
213.65)

100

80.12

(17.09,
149.75)

100

78.65

(31.06,
137.32)

100

75.26

(44.90,
119.94)

100

IL‐15

0.10

(0.10, 22.19)

5

0.10

(0.10, 0.10)

0

0.10

(0.10, 0.10)

0

0.10

(0.10, 19.50)

20

IL‐17

45.41

(0.10,
114.89)

95

18.42

(0.10,
125.02)

80

11.13

(0.10, 43.28)

72

1.96

(0.10, 40.42)

50

% Above
Detection

Median

Min, Max

(10.78,
1027.91)

100

29.06

6625.92

(1055.03,
20000.00)

100

IL‐2

5.59

(0.10, 62.02)

IL‐4

2.45

IL‐5

Cytokine

Median

Min, Max

IL‐1β

99.10

IL‐1ra
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Table 3 Continued: Wound Fluid Cytokine Concentrations (pg/ml) Over Time

Eotaxin

0.10

(0.10,
206.96)

20

0.10

(0.10,
76.56)

25

0.10

(0.10,
123.34)

22

0.10

(0.10,
563.34)

40

FGF‐B

108.11

(15.43,
258.90)

100

44.47

(0.10,
105.29)

95

32.11

(0.10,
78.80)

83

11.16

(0.10,
59.55)

70

G‐CSF

2905.93

(695.92,
9000.00)

100

641.23

(100.15,
7853.37)

100

125.01

(24.19,
1011.87)

100

151.39

(29.75,
398.60)

100

GM‐CSF

152.04

(15.99,
1735.42)

100

121.43

(17.08,
576.73)

100

99.97

(15.69,
277.05)

100

95.16

(3.76,
297.60)

100

IFN‐γ

184.82

(101.55,
307.76)

100

148.19

(64.90,
294.48)

100

148.42

(15.20,
310.96)

100

165.63

(31.46,
251.36)

100

IP‐10

4502.75

(571.16,
36148.43)

100

4409.04

(865.25,
23078.36)

100

5487.88

(462.46,
50000.00)

100

4309.51

(883.89,
50000.00)

100

MCP‐1

3278.38

(2102.40,
4575.40)

100

2526.23

(500.60,
3238.87)

100

2286.12

(1310.25,
3597.04)

100

2206.73

(1464.71,
2963.51)

100

MIP‐1α

37.84

(6.36,
315.23)

100

10.25

(4.50,
131.74)

100

12.77

(0.56,
40.93)

100

11.48

(2.24,
200.65)

100

PDGF‐bb

266.78

(63.81,
6561.56)

100

169.12

(50.15,
10000.00)

100

154.27

(3.62,
3129.84)

100

126.71

(19.22,
2646.23)

100

MIP‐1β

1538.40

(220.52,
7327.41)

100

419.48

(162.63,
3936.04)

100

300.88

(98.27,
829.54)

100

369.93

(113.31,
1662.61)

100

RANTES

928.28

(30.78,
4683.14)

100

143.74

(4.70,
6845.77)

100

51.30

(2.01,
622.37)

100

36.45

(0.10,
360.12)

100

TNF‐α

45.52

(19.05,
171.28)

100

28.64

(7.54,
77.33)

100

21.63

(0.10,
47.02)

95

16.32

(4.58,
113.06)

90

VEGF

1226.91

(259.97,
2547.26)

100

1239.62

(296.12,
2538.70)

100

1067.25

(50.06,
4729.50)

100

1284.91

(238.35,
2921.29)

100

Note: % Above Detection is the percentage of samples for which we can be fairly certain that the compound was present.
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Using mixed model analysis to show trends among cytokines over time, IL1, IL-2, IL-6, IL-9, IL-10, IL-17, FGF-basic, G-CSF, MIP-1α, MIP-1β, PDGF-bb,
RANTES, and TNF- decreased, and all were significant with the exception of PDGFbb. IL-5 showed a significant increase over time. IL-8 decreased over 48 to 72 hours,
then significantly increased at 96 hours. The remaining concentrations remained stable
over time. IL-1ra, IL-6, IL-8, G-CSF, IP-10, MCP1, MIP-1β, RANTES and VEGF were
present in the highest concentrations. Wound fluid concentrations showed trends that
were higher on post-operative day 1 than all other time points with the exception of IL-5,
which increased over time, and IL-7, IL-12, IL-15, eotaxin, IP-10 and VEGF, which
remained stable. Plots illustrating some of the wound fluid mediator changes over time
are presented in Appendix B.
Serum Biochemical Mediator Profiles
The same panel of cytokine, chemokine, and growth factor levels was measured
in serum preoperatively and 48 hours post-operatively again using mixed model

analysis to show trends among cytokines over time; levels are summarized in Table
4. A significant decrease over time was observed in IL-1, IL-4, IL-5, IL-7, IL-10, IL12, IL-13, IL-17, FGF-basic, IFN-γ, IP-10, MIP-1α, MIP-1β, PDGF-bb, TNF, and
VEGF. Both IL-6 and MCP-1 showed significant increases over time.
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Table 4
Serum Cytokine Concentrations (pg/ml) Over Time and Percentage of Samples Above the Minimal Detection Level
24 Hours Post‐Op
Cytokine
IL‐1β

Median
Conc.
4.68

IL‐1ra

48 Hours Post‐Op

(2.09, 258.32)

% Above
Detection
100

Median
Conc.
2.74

(0.94, 5.9)

% Above
Detection
100

337.88

(121.52, 9770.27)

100

220.52

(82.94, 1531.51)

100

IL‐2

6.00

(0.10, 68.90)

61

1.07

(010, 17.74)

50

IL‐4

5.98

(1.54, 12.09)

100

5.80

(3.20, 12.14)

100

IL‐5

6.01

(1.31, 15.20

100

4.94

(2.27, 11.71)

100

IL‐6

18.20

(7.14, 972455.02)

100

46.17

(13.01, 200.50)

100

IL‐7

14.20

(5.82, 25.16)

100

9.57

(4.92, 20.16)

100

IL‐8

29.59

(16.61, 6571.63)

100

25.93

(18.36, 55.60)

100

IL‐9

20.07

(0.10, 18143.43)

89

5.75

(0.10, 12185.77)

58

IL‐10

9.65

(0.10, 166.08)

95

5.01

(0.10, 21.86)

75

IL‐12

27.27

(6.77, 352.09)

100

17.75

(0.10, 34.63)

92

IL‐13

6.09

(1.93, 106.02)

100

4.31

(0.10, 18.59)

92

IL‐15

0.10

(0.10, 58.28)

11

0.10

(0.10, 0.10)

0

IL‐17

81.34

(0.10, 184.97)

95

60.30

(2.94, 150.00)

92

Eotaxin

0.10

(0.10, 284.73)

34

0.10

(0.10, 508.92)

83

FGF‐B

58.59

(19.95, 173.04)

100

29.31

(0.10, 65.76)

100

G‐CSF

124.08

(74.74, 6574.77)

100

82.93

(25.12, 197.15)

8

0.10

(0.10, 292.95)

33

0.10

(0.10, 253.06)

8

IFN‐γ

209.61

(121.58, 313.55)

100

154.58

(78.79, 284.79)

100

IP‐10

613.32

(160.54, 8767.74)

100

271.36

(110.70, 711.67)

100

MCP

34.96

(13.40, 3728.91)

100

35.86

(12.75, 125.61)

100

MIP‐1α

7.78

(4.04, 126.46)

100

4.81

(2.19, 9.52)

100

1651.73

(116.28, 5462.59)

100

1612.12

(595.05,3838.94)

100

MIP‐1β

64.38

(33.52, 2392.48)

100

42.24

(32.31, 61.94)

100

RANTES

2991.03

(494.54, 4574.49)

100

2929.11

TNF‐α

44.60

(13.38, 77.03)

100

30.49

(10.95, 69.42)

100

VEGF

27.25

(7.68, 1759.98)

100

17.12

(0.10, 38.30)

92

GM‐CSF

PDGF‐bb

Min, Max

Min, Max

(1990.15,4511.44)

100

Note: % Above Detection = percentage of samples for which we can be fairly certain that the compound was present.

Correlation of Stress Measures with Serum and Wound Fluid Mediators
This study showed several significant correlations between stress measures and
levels of the selected biochemical mediators. Mediator data were log transformed due to
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the large range and non-normal distribution of values. In serum, there was a significant
negative correlation between IL-5 and PSS and IES-R scores at baseline. MIP-1 and
MIP-1 showed significant positive correlations with the IES-R. Two days after surgery,
only RANTES showed a significant negative correlation with the IES-R. These data are
summarized in Table 5. While there appeared to be high correlations for many of the
serum mediators and stress measures, many of them were not significant.
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Table 5
Pearson’s Correlations of Stress Measures with Serum Cytokines
Measures at Baseline

Measures at 48 Hours

IL‐1β

PSS
n=18
‐0.0028

IES
n=18
0.4461

VAS
n=13
‐0.0042

IES
N=11
‐0.1490

VAS
N=11
0.2082

IL‐1ra

‐0.0922

0.3857

‐0.1385

0.3266

0.5068

IL‐2

‐0.1879

0.3991

‐0.2173

0.4930

0.4276

IL‐4

‐0.0207

‐0.2203

0.2248

‐0.2466

0.0722

IL‐5

‐0.5051*

‐0.4713*

0.1175

0.2505

0.5168

IL‐6

‐0.0470

0.3976

‐0.0007

0.2380

0.0072

IL‐7

‐0.4468

0.0821

0.1395

‐0.1294

0.2429

IL‐8

‐0.1202

0.3414

0.1512

0.0003

0.0439

IL‐9

‐0.2366

0.2019

‐0.0673

0.1092

0.1700

IL‐10

‐0.1701

0.3756

0.0089

0.2283

0.5522

IL‐12

‐0.2043

0.2752

0.3115

0.2456

0.4217

IL‐13

‐0.0772

0.3683

0.1262

0.3114

0.4152

IL‐15

0.3598

0.3671

‐0.0682

‐0.0000

‐0.0000

IL‐17

0.4410

0.2607

0.2925

‐0.4125

‐0.1104

Eotaxin

0.0777

0.0653

0.0497

0.5836

0.4179

FGF‐B

‐0.1991

0.1428

0.0345

‐0.4142

‐0.1974

G‐CSF

‐0.1381

0.3089

‐0.2260

‐0.4819

‐0.2609

GM‐CSF

‐0.1419

0.4675

0.2890

0.0116

0.0147

IFN‐γ

‐0.0685

0.3921

0.2849

‐0.0327

0.2077

IP‐10

0.0661

0.3256

0.0983

‐0.1199

0.1019

MCP‐1 (MCAF)

‐0.0991

0.3107

‐0.2268

0.4793

0.1690

MIP‐1α

0.2911

0.5407*

0.2058

‐0.4247

0.0263

PDGF‐bb

‐0.0088

‐0.2025

0.2931

0.0259

0.1510

MIP‐1β

0.1102

0.4701*

0.1765

‐0.2932

‐0.2289

RANTES

0.0385

‐0.3253

‐0.3141

‐0.6104*

‐0.5480

TNF‐α

‐0.1592

0.0564

0.0610

‐0.0939

0.2767

VEGF

‐0.1882

0.3322

0.3588

0.1569

0.2884

Note. (* p<0.05); IES = Impact of events scale; PSS = Perceived Stress Scale; Analog Scale = 100mm visual analog scale.
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Relationships between wound fluid biochemical mediators and stress measures at
48 hours post-surgery were examined. As seen in Table 6, there were some high
correlations, but many were not statistically significant. However, there was a significant
positive correlation found between IL-2 and IES-R scores and a significant negative
correlation between eotaxin and IES-R scores. Significant positive correlations were
found between VAS scores and eotaxin, and significant negative correlations were
identified between the VAS and IL-12 as well as VEGF.
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Pearson’s Correlations of Stress Measures with
Wound Fluid Mediators at 48 Hours Post Surgery

IL‐1β

IES
N=14
0.4762

VAS
N=14
0.0218

IL‐1ra

0.3055

0.0574

IL‐2

0.5839*

0.2653

IL‐4

0.1923

0.1895

IL‐5

0.3586

0.2754

IL‐6

0.0455

‐0.4053

IL‐7

0.0138

‐0.4420

IL‐8

0.1439

0.0967

IL‐9

0.2638

‐0.0778

IL‐10

‐0.0253

‐1929

IL‐12

‐0.2410

‐5459*

IL‐13

0.3101

1629

IL‐15

0.0000

0.0000

IL‐17

0.1496

0.0499

Eotaxin

0.7983*

0.7034*

FGF‐B

0.1844

‐0.2083

G‐CSF

0.2654

‐0.1082

GM‐CSF

‐0.2116

‐0.2783

IFN‐γ

0.0342

‐0.1336

IP‐10

0.0040

0.0354

MCP‐1

‐0.1039

0.3428

MIP‐1α

0.0195

‐0.0442

PDGF‐bb

0.1968

0.3515

MIP‐1β

0.0582

‐0.1293

RANTES

0.0290

0.2936

TNF‐α

0.1334

‐0.2566

VEGF

0.2945

‐0.6063*

Note. (* p<0.05); IES = Impact of events scale; VAS = 100mm visual analog scale.
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Discussion
Numerous investigators have shown a relationship between psychological stress
and wound healing, and some have specifically explored that association with wound
biochemical mediators such as cytokines (Broadbent, Petrie, Alley, & Booth, 2003;
Glaser et al., 1999; Kiecolt-Glaser et al., 2005). To our knowledge, this is the first study
to explore those relationships in respect to the local surgical wound environment,
specifically surgical wound fluid mediators over time. We believe this is also the first
study characterizing wound fluids in abdominal muscle flap donor site wounds, a wound
type that has no associated pathologic abnormality such as cancer.
We assumed this would be a stressful period for women and that higher stress
might affect wound biochemical mediators. However, the low levels of perceived stress,
based on the psychological scales used, leads us to believe that our participants were not
experiencing high levels of stress and that stress may not have been the most appropriate
variable to measure. Additionally, low mean stress scores may have been related to the
small sample size, as many of the study participants had high scores on their
questionnaires. Perhaps pre-surgical “worry” would have been a better variable to
measure. Broadbend et al. (2003) noted that higher levels of pre-surgical worry were
associated with greater post-operative pain and longer recovery times, as well as poorer
self-ratings on recovery
Wound healing occurs in complex overlapping phases. In our study, time points
fell within the inflammatory phase, so we expected to see higher levels of those
cytokines, chemokines, and/or growth factors that are active in the inflammatory phase of
healing. Interestingly, we were able to detect all 27 selected mediators at some level in
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wound fluid samples and the concentration of all cytokines was greatest on day 1 postoperatively. These findings are similar to those of DiVita et al. (2006) with the exception
of VEGF, where they reported higher levels of VEGF on day 4.
We chose to report even those mediator levels that were lower than the 50%
detection limit, because even if those concentrations were low, some participants did
have detectable levels and thus the data may be meaningful. Some of these cytokines
have not been extensively reported for wound fluid, and at this time we do not know what
role they may play, if any, in the wound healing cascade. Table 4 provides quantitative
measurements of all 27 factors detected in the surgical wound fluid using the Bio-Rad 27plex plate. Overall, the ranges detected were similar to the concentrations of acute wound
fluid cytokines previously reported (Baker & Leaper, 2000). Interestingly, some studies
showed varying concentrations of cytokines at the same time point post-operatively. This
is most likely due to different assays having different sensitivities and specificities.
Differences in surgeries and surgical site may also play a role. For example, Baker and
Leaper (2000) demonstrated that cytokine concentrations vary based on the breast
surgical site verses the colon surgical site.
Inflammatory cytokine production was highest in the first 24 hours post
wounding, which is consistent with other studies (Baker, El-Gaddal, Aitken, & Leaper,
2003; Chow, Loo, Yuen, & Cheng, 2003; DiVita et al., 2006). As reflected in the daily
wound fluid profiles, IL-1, IL-6, and IL-8 concentrations were greatest at 24 hours and
then decreased over time. These mediators are released by neutrophils and monocytes,
which are the predominate cell types found in the site of injury in the early inflammatory
phase, recruited to the wound by chemotactic factors released during hemostasis and by
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mast cells (Li, Chen, & Kirsner, 2007). TNF- was also found to peak earlier and to
decrease over time, a finding consistent with others (Hubner et al., 1996).
IL-6 was present in the highest median concentration (56489.28 pg/ml) of all
cytokines on day 1 or any other single time point. The concentration remained high but
significantly decreased over time. IL-6 has been identified as an early marker of the
systemic inflammatory response and tissue damage (Loo et al., 2007), and thus would be
expected to be elevated following a large abdominal surgical operation such as the one in
our study. Prolonged elevations in levels of IL-6 have been associated with increased
scarring in the wound site (Rumalla & Borah, 2001), but we did not follow our
participants long enough to evaluate scarring.
IL-1 levels declined significantly from 24 to 72 hours post surgery. IL-1 exists in
two isoforms, IL-1 and IL-1, and plays a vital role in collagen synthesis, fibroblast
growth, and keratinocyte growth, as well as activation of neutrophils (Efron & Moldawer,
2004). However, elevated levels of IL-1 beyond the first 7 days of wound healing have
been associated with poor wound healing outcomes (Barone et al., 1998; Trengove,
Bielefeldt-Ohmann, & Stacey, 2000). This coincides with our findings in that there were
no wound healing complications observed postoperatively.
FGF basic demonstrated a peak at post-operative day 1 and a steadily declined
through day 4, which is consistent with previous studies (Baker, Kumar, Melling, &
Whetter, 2008; Nissen, Polverini, Gamelli & DiPietro, 1996). FGF basic is thought to
initiate angiogenesis in the wound until VEGF can take over (Baker, Kumar, Melling &
Whetter, 2008), but both cytokines act synergistically to stimulate endothelial cell
function, migration, and proliferation (Barrientos, Stojadinovic, Golinko, Brem, &
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Tomic-Canic, 2008). VEGF in our study remained stable from 24 to 96 hours
postoperatively. It has been reported that VEGF peaks on day 7 following injury
(Kapoor, Howard, Hall, & Appeltoon, 2004), which was outside of the time frame for our
study and thus may explain why we did not observe a significant increase.
Forsberg et al. (2008) found that IL-13 and RANTES levels were suppressed in
closed traumatic leg wounds and showed a high correlation with wound dehiscence
following closure of those wounds. RANTES and IL-13 were not suppressed in this
study. IL-13 remained stable over time and RANTES was found at high levels at 24
hours and then significantly decreased over time. Again, this finding coincides with the
fact that our participants had no immediate wound healing problems; our wounds also
were surgically precise as opposed to traumatic injuries.
Several significant correlations between stress measures and mediator levels were
observed. However, these correlations are not similar to those previously reported in the
literature. Part of this may be related to the design of this study. We examined
correlations of stress measures with wound fluid over time, while other studies looked at
various psychological measures and wound fluid at specific time points. Glaser et al.
(1999) examined the relationship of perceived life stress and the production of cytokines
in the wound fluid of experimentally created skin blisters. Greater stress was associated
with decreased cytokine production (IL-1 and IL-8) at the blister site 5 hours and 24
hours after wounding. Using the same wound model, Kiecolt-Glaser et al. (2007) looked
at the effect of hostile marital relationships on wound fluid cytokines. They found that
wound fluid mediators (specifically IL-6, TNF, and IL-1) were decreased after
conflict. Broadbent et al. (2003) reported that greater perceived stress 1 month before
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surgery led to lower levels of IL-1 in wound fluid 20 hours post surgical procedure.
Again, this inconsistency in our findings is very likely due to the low levels of reported
stress in our sample.
Limitations
This pilot study was limited by the small sample size, making statistical
inferences difficult. Even so, meaningful biochemical mediator patterns were identified in
our sample. Earlier studies by Takamiya, Fujita, Saigusa, and Aoki (2007) also
demonstrated that meaningful cytokine patterns can be found with a sample as small as 5.
Because participants had lower-than-anticipated levels of perceived stress, power
for analyses of psychological stress and biochemical mediators was limited. All
correlations between stress measures and biological measures in the study must be
viewed with caution.
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Conclusion
The purpose of this study was to gain a better understanding of psychological
stress and its potential effects on the surgical wound environment. Stress has been shown
to impact health, and wound healing is an additional area in which increased
psychological stress has been associated with poorer outcomes. Identifying those
individuals who may be experiencing stress and implementing interventions to lower that
stress may have a positive impact on their health, and specifically on wound healing.
While participants in our study overall did not show high levels of stress, characterization
of the surgical wound environment and its biochemical mediators over time provides
valuable insight into the physiological mechanisms of wound healing.
Wound fluid characterization provides the opportunity to obtain information
reflecting the status of the wound at specific time points and holds potential for the
development of specific biomarkers of impaired healing (Yager, 2007). Generally,
“biomarkers” are biochemical mediators clinicians use to guide clinical practice.
Cardiology, immunology, and endocrinology all use biomarkers in practice, yet
traditional serum biomarkers may not be the most appropriate measures to assist in
decision making in the case of wound healing. Biomarkers in wound fluid are produced
locally in the wound bed, are the most characteristic of activity in the wound
environment, and are less susceptible to the influences of systemic elevation of white
blood cells and pro-inflammatory cytokines following trauma, treatment interventions
such as surgery, or acute elevations in circulating pro-inflammatory cytokines secondary
to infection or trauma (Forsberg et al., 2008). Thus, wound fluid biomarkers may
ultimately prove to be clinically valuable for assessing wound healing.
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Wound fluid biomarkers may provide insight into specific mediators that, when
deficient or present in excess, contribute to poor or delayed healing and may one day
guide specific treatment options for wounds. Such knowledge would guide decisions to
either replace the deficient factor or provide an agonist or one that may down-regulate
other inflammatory mediators. Wound fluids may one day serve as prognostic markers of
healing, may aid in predicting adverse wound outcomes, and may be beneficial in
planning additional therapies post-surgery such as radiotherapy or chemotherapy. We
may be able evaluate wound fluids in order to optimize outcomes and prevent
complications such as slowed wound healing, infection, seroma development, and tissue
flap necrosis.
Understanding the role of specific cytokines in wound healing may lead to the
development of direct wound healing therapies to hasten healing in the those patients
suffering from chronic wounds. One current example is that of commercially prepared
recombinant human variants of PDGF-bb (Becaplermin) that have been shown to
clinically improve angiogenesis, collagen deposition, and granulation tissue formation in
diabetic neuropathic foot ulcers and pressure ulcers.
Lastly, this study paves the way for additional work in PNI and wound healing.
While overall our population was not stressed, there were some correlations among the
wound fluid environment and stress. Further research involving the analysis of wound
fluid may provide insight into the associations of psychological stress with cellular
mechanisms in the local wound site.
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APPENDIX A
27‐Plex Chemical Mediators, Their Source and Their Roles
Mediator
Interleukin 1β
(IL‐1β)

Interleukin 2
(IL‐2)

Source
‐ Produced by
neutrophils, monocytes,
macrophages and
keratinocytes.
‐ Kertinocytes release IL‐
1 immediately upon
wounding (4,5)
‐ Variety of immune cells,
adipocytes and epithelial
cells
‐ T lymphocytes, NK cells
(1)

Interleukin 4
(IL‐4)

‐ Basophils, Helper T‐
Cells, Mast cells (11)

Interleukin 5
(IL‐5)

‐ Helper T cells, Mast cells
(11)

Interleukin 6
(IL‐6)

‐ Polymophonuclear cells
(PMNs) and fibroblasts 2
‐Vascular endothelial cells
‐Activated T Cells (11)

Interleukin 7
(IL‐7)

‐ Stromal cells of bone
marrow and thymus and
keratinocytes (16)

‐ Immune response
‐ Involved in estracellular
matrix production (16)

Interleukin 8
(IL‐8)

‐ Macrophages
‐ Endothelial cells
‐ Lymphocytes (11)

Interleukin 9
(IL‐9)

‐Activated helper T‐
lymphocytes (11)

‐ Macrophage and PMN
activation and chemotaxis
‐ Involved in keratinocyte
maturation (3)
‐Function in wound
healing has not been
identified

Interleukin 10
(IL‐10)

‐ Released by
macrophages and T
lymphocytes (1)

Interleukin 1ra
(IL‐1ra)

Wound Healing Function
‐Stimulates keratinocyte
migration and
proliferation as well as
activates fibroblasts and
stimulates secretion of
FGF‐7 (4,5)

Systemic Function
‐Mediates the action of
macrophages, B and T cells,
inflammation and fever,
acute phase response,
hematopoiesis

‐ Natural antagonist of IL‐
1 function

‐ Natural antagonist of IL‐1
function

‐T‐cell activation
‐Involved in infiltration of
inflammatory cells and
fibroblasts (1)
‐ Stimulates Fibroblast
proliferation
‐ Involved in collagen
synthesis
‐ Inhibits TNF, IL‐1 and
IL‐6 expression (3)
‐ Promote the infiltration
of eosinophils into the
wound bed (21)
‐ Potent stimulator of
fibroblast proliferation
‐ Inflammation,
angiogenesis, re‐
epithelialization, collagen
deposition, tissue
remodeling (24)

‐ Augments proliferation of
T‐lymphocytes, B‐cell
proliferation and NK cell
activity (17)
‐ Inhibits production of
inflammatory cytokines (18)

‐ Inhibits gene expression
and synthesis of those
cytokines that are thought
to be inflammatory, such
as TNF‐, IL‐1 and IL‐6.
‐ Inhibits macrophage and
PMN activation (1)
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‐ Eosinophil growth and
differentiation (11, 21)
‐ Promotes inflammation
‐ Induces acute phase
proteins
‐ Activates helper T (Th)
cells,
‐ Promotes antibody
synthesis
‐ Promotes hematopoiesis
(11)
‐ Stem cell differentiation
‐ Promotes immune effector
function in T‐lymphocytes,
NK‐cells, monocytes and
macrophages (16)
‐ Acts as a neurotrophil
chemoattractant (11)
‐ Stimulates T‐lymphocytes,
and mast cells, epithelial
cells, macrophages,
eosinophils.
‐ Decreases inflammatory
effects of monocytes and
macrophages (25)
‐ Cytokine production
‐ Inhibits Th1 cell activity
(11)
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Mediator
Interleukin 12
(IL‐12)

Source
‐ T‐cells
‐ macrophages
‐ Dendritic cells (11)
‐ Activated T cells (11)

Wound Healing Function
‐Function in wound
healing has not been
identified
‐ Inhibits macrophage
activity (23)

Interleukin 15
(IL‐15)

‐ Monocytes (11)

Interleukin 17
(IL‐17)

‐ Activated memory CD4+
cells (11)

Eotaxin

‐ Produced by a variety of
tissues and cells types
(13)
‐Released by
macrophages and
endothelial cells (1,3)

‐ May play a role in
proliferation of regulatory
T‐cells involved in
inflammation (28)
‐ Low levels may play a
role in chronic infections
of nails, skin and mucosa
by Candida albicans (29)
‐ Eosinophil and
endothelial cell
chemotaxis (13,15)
‐ Important mediator of
wound angiogenesis and
epithelialization.
‐ Stimulates fibroblast and
keratinocyte proliferation
and migration (1,3)
‐ Modulates immune
response
‐ Promotes keratinocyte
proliferation

Interleukin 13
(IL‐13)

FGF‐basic

Granulocyte colony‐
stimulating factor
(G‐CSF)
Granulocyte‐
macrophage colony‐
stimulating factor
(GM‐CSF)

‐ A variety of cells
including bone marrow
stromal cells, fibroblasts,
endothelial cells and
macrophages (19)
‐ T‐cells
‐ Fibroblasts

Interferon‐
(IFN‐)

‐ Lymphocytes and NK
Cells (12, 20)

Interferon‐‐inducible
protein‐10
(IP‐10)
Monocyte chemo
attractant protein‐1
(MCP‐1)(MCAF)

‐ T‐cells and NK cells (26)

Macrophage
inflammatory protein
(MIP‐1α)
Macrophage
inflammatory protein
(MIP‐1β)

‐ Lymphocytes (11)

‐Keratinocytes,
endothelial cells,
macrophages (14)

‐ Fibroblasts (11)

‐ Enhances neutrophil
number and function at
the wound site.
‐ Increases keratinocyte
proliferation
‐ Up regulates IL‐6 (4)
‐ Inhibit fibroblast
chemotaxis and
proliferation
‐ Impacts collagen
production (12)
‐ Associated with
lymphocyte production
(14)
‐ Chemo attractant and
activator of monocytes,
mast cells and
lymphocytes (14)
‐ Chemo attractant for
monocytes and T cells (10)
‐ Chemo attractant for
monocytes and T cells (10)
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Systemic Function
‐ Activates NK Cells
‐ T‐cell activation (11)
‐ Activates B‐cells
‐ Inhibits Th1 cells
‐ Inhibits proinflammatory
cytokine production
‐ Enhances IFN‐γ production
(11)
‐ Stimulates growth of T and
NK cells (11)
‐ Induce synthesis of
cytokines that promote T‐
cell dependent inflammation
(11)
‐Eosinophil chemotaxis (13)
Response to injury, divers
role in cell regulation,
proliferation, migration and
differentiation during
embryonic development
(15)
‐Enhances myeloid cell
proliferation, maturation
and function (19)
‐ Stimulates proliferation,
differentiation and enhances
function of neutrophils,
monocytes, macrophages,
eosinophils and dendritic
cells (27)
‐Variety of immunological
functions
‐ Activates macrophages
(20)
‐ Inhibits endothelial cell
proliferation
‐ Anti‐angiogenic (26)
‐ Stimulates monocytes,
memory T cells and NK cells
(10)
‐ Chemo attractant for
monocytes and T cells
‐ Antiviral defense (10)
‐ Chemo attractant for
monocytes and T cells (10)
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Mediator
Platelet Derived
Growth Factor
(PDGF‐bb)
(PDGF‐bb is one of
three isomers of PDGF,
including PDGF‐aa and
PDGF‐ab, and is the
most widely studied.)

Source
‐ Synthesized by many
different cell types, but it
is usually the platelets,
macrophages and
keratinocytes which are
responsible for synthesis
of this growth factor (1)

Regulated upon
activation normal T‐
cell expressed and
secreted
(RANTES)

‐Produced mainly by
keratinocytes during
tissue repair (6, 7)

Tumor Necrosis
Factor
(TNF‐α)

‐Released primarily by
macrophages
‐ T‐cells
‐ B‐cells
‐ NK cells (11)

Vascular Endothelial
Growth Factor
(VEGF)

Platelets, neutrophils,
macrophages, endothelial
cells, smooth muscle cells,
keratinocytes, fibroblasts
(24)

Wound Healing Function
‐ Potent mitogenic,
chemotactic and
angiogenic growth factor
essential in initiating and
sustaining wound healing
(1,9)
‐ Chemo attractant for
neutrophils, monocytes.
‐ Stimulates activation of
macrophages
‐ Essential in collagen
synthesis and collagenase
activation (12)
‐ Attracts eosinophils, T
lymphocytes and
monocytes
‐ Involved in angiogenesis
(6,7)

Systemic Function
‐ Activation of immune cells
and fibroblasts (1)

‐Crucial in initiating
immune system cascade
at the time of injury
‐Recruitment and
maturation of the cellular
components of
inflammation.(8, 11)
‐Involved in hemostasis,
increased vascular
permeability and
increased vascular
proliferation (1)
‐ Angiogenesis and
granulation tissue
formation (12)

‐ Endothelial activation,
cytokine expression in
macrophages.
‐ Initiates immune cascade
during host response to
injury or bacteria
‐ Promotes inflammation
(11)
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‐ Monocyte/macrophage T‐
cell chemotaxis (6,7)

‐ Angiogenesis (1)
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Appendix B
Wound Healing Cytokine Patterns Over Time
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Appendix B: Representation of some of the daily changes of cytokine concentrations in drain fluid (DF). DF was collected at 24,
48, 72 and 96 hours post‐surgery.
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STUDY ID # _________

A Pilot Study of Perceived Stress and Surgical Wound Cytokine Patterns
IMPACT OF EVENT SCALE-REVISED
Weiss, D. S., & Marmar, C. R. (1997). The Impact of Event Scale—Revised. In J. P. Wilson, & T. M. Keane (Eds.), Assessing
psychological trauma and PTSD: A handbook for practitioners (pp. 399–411). New York: Guilford Press.

Instructions: The following is a list of difficulties people sometimes have after stressful life events. Please
read each item, and then indicate how distressing each difficulty has been for you during the past 7 days with
respect to your surgery. How much were you distressed or bothered by these difficulties?
Not
at all

A little
bit

Moderately

Quite
a bit

Extremely

1

Any reminder brought back feelings about it.

0

1

2

3

4

2

I had trouble staying asleep.

0

1

2

3

4

3

Other things kept making me think about it.

0

1

2

3

4

4

I felt irritable and angry.

0

1

2

3

4

5

I avoided letting myself get upset when I thought about it
or was reminded of it.

0

1

2

3

4

6

I thought about it when I didn’t mean to.

0

1

2

3

4

7

I felt as if it hadn’t happened or wasn’t real.

0

1

2

3

4

8

I stayed away from reminders about it.

0

1

2

3

4

9

Pictures about it popped into my mind.

0

1

2

3

4

10

I was jumpy and easily startled.

0

1

2

3

4

11

I tried not to think about it.

0

1

2

3

4

12

I was aware that I still had a lot of feelings about it, but I
didn’t deal with them.

0

1

2

3

4

13

My feelings about it were kind of numb.

0

1

2

3

4

14

I found myself acting or feeling like I was back at that time.

0

1

2

3

4

15

I had trouble falling asleep.

0

1

2

3

4

16

I had waves of strong feelings about it.

0

1

2

3

4

17

I tried to remove it from my memory.

0

1

2

3

4

18

I had trouble concentrating.

0

1

2

3

4

19

Reminders of it caused me to have physical reactions,
such as sweating, trouble breathing, nausea, or a
pounding heart.

0

1

2

3

4

20

I had dreams about it.

0

1

2

3

4

21

I felt watchful and on guard.

0

1

2

3

4

22

I tried not to talk about it.

0

1

2

3

4
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Perceived Stress Scale
Cohen, S., Kamarck, T., Mermelstein, R. (1983). A global measure of perceived stress.
Journal of Health and Social Behavior, 24, 385-396.
The questions in this scale ask you about your feelings and thoughts during the last month. In each
case, please indicate with a check how often you felt or thought a certain way.
Never Almost Somenever times

Fairly
often

Very
often

1. In the last month, how often have you been upset
because of something that happened unexpectedly?

0

1

2

3

4

2. In the last month, how often have you felt that you were
unable to control the important things in your life?

0

1

2

3

4

3. In the last month, how often have you felt nervous and
"stressed"?

0

1

2

3

4

4. In the last month, how often have you felt confident
about your ability to handle your personal problems?

0

1

2

3

4

5. In the last month, how often have you felt that things
were going your way?

0

1

2

3

4

6. In the last month, how often have you found that you
could not cope with all the things that you had to do?

0

1

2

3

4

7. In the last month, how often have you been able to
control irritations in your life?

0

1

2

3

4

8. In the last month, how often have you felt that you were
on top of things?

0

1

2

3

4

9. In the last month, how often have you been angered
because of things that were outside of your control?

0

1

2

3

4

10. In the last month, how often have you felt difficulties
were piling up so high that you could not overcome them?

0

1

2

3

4
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Valentina Sage Lucas
8345 Studley Road
Mechanicsville, VA 23116
Home: (804) 746-7123
VSLUCAS@vcu.edu
EDUCATION:

Virginia Commonwealth University/Medical College of Virginia, School of Nursing, Richmond, VA.
Currently PhD (candidate) in Nursing, expected graduation Fall 2012.

Virginia Commonwealth University/Medical College of Virginia, School of Nursing, Richmond, VA.
Dual Master of Science in Adult Health Nursing and Psych/Mental Health Nursing, May 1999.
Virginia Commonwealth University/Medical College of Virginia, School of Nursing, Richmond, VA.

Bachelor of Science in Nursing – Summa Cum Laude, December 1997.

Virginia Commonwealth University, School of Humanities and Sciences, Richmond, VA.
Bachelor of Science in Biology, December 1990.

PROFESSIONAL LICENSURE AND CERTIFICATIONS:
Registered Nurse, Virginia # 0001157454
Adult Health Nurse Practitioner, Virginia #0024164023
Authorization to Prescribe, Virginia #0017136880
CPR for the health professional
DEA#ML0704242
Certified Adult Nurse Practitioner, American Nurses Credentialing Center #342425-21
WORK EXPERIENCE:
Virginia Commonwealth University Health System, Division of Plastic Surgery
Adult Nurse Practitioner, March 2000 to present
- Provide care for the plastic surgical patient as well as individuals with chronic and difficult to heal wounds.
Assess, treat and case manage.
- Provide education to residents, fellows, nurses and students in a variety of settings and formats.
- Provide home health visits for individuals with wounds who are physically unable to come to the clinic.
- Provide pre-op and post operative and follow up care to plastic surgery patients
- Current procedures approved to carry out include sharp debridement, biopsy, laser procedures, reconstructive
nipple tattooing, and sclerotherapy
- Research coordinator for ongoing clinical trials for the practice
Virginia Commonwealth University, School of Nursing, Dept of Adult Health Nursing Systems
Graduate Adjunct Faculty, August 2010 to present
- Course faculty for NURS 676: Adult primary practicum
- Course faculty for NURS 679: Adult acute practicum
Hanover Medical Group, Mechanicsville, Virginia.
Adult Nurse Practitioner, June 1999 to March 2000
- Internal medicine/infectious disease practice addressing a wide variety of illnesses including, but not limited to,
HTN, diabetes, HIV, hepatitis, STD’s, asthma, COPD, bronchitis, allergies, dermatological concerns, obesity, sports
medicine, well woman and routine physical exams, minor surgeries such as skin biopsy and suturing.
- Address a variety of mental health issues, such as depression, bipolar disorder, anxiety and substance detox.
Virginia Commonwealth University/Medical College of Virginia, School of Nursing, Richmond, VA.
Graduate Research Assistant for PNI Based Stress Management Research, Feb. 1998 - May1999.
- Psychoneuroimmunology based research involving stress management in individuals with HIV.
- Primarily responsible for participant recruitment, scheduling and study promotion in the community.
Medical College of Virginia Hospitals, Richmond, Virginia.
Registered Nurse in the Woman’s Specialties Unit, January 1998 to June 1999.
- Care of a variety of patient conditions, including but not limited to gyn-surgery, gyn-oncology, administer
chemotherapeutic agents, care of general medical conditions and postpartum care.
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Medical College of Virginia Hospitals, Richmond, Virginia.
Nursing Assistant in the Burn – Surgical Trauma Intensive Care Unit, Dec. 1996 – Dec. 1997.
- Assisted in care of patients in the burn and surgical trauma ICU, which included, but was not limited to, wound
care, burn debridement, am care, feeding and ambulation.
McGuire Veterans Administration Medical Center, Lipid Research, Richmond, Virginia.
Biological Science Laboratory Technician, October 1991 – December 1996.
- Conduct research in cholesterol metabolism in in-vivo and in-vitro models, excelling in molecular applications.
- Represented lab at national meetings.

PUBLICATIONS
 Lucas, V.S. (2011). Psychological stress and wound healing in humans: What we know. WOUNDS: A
Compendium of Clinical Research and Practice. 23 (4), 76-83.
 Lucas, V.S. & King, A. (2010) Wound healing for the plastic surgery nurse. Plastic Surgical Nursing,
30(3), 158-169.
 Pozez, A.L., Aboutanous, S.Z., Lucas, V.S. (2007) Diagnosis and treatment of uncommon wounds.
Clinics in Plastic Surgery, October, 749-764.
 McCain, N.L., Munjas, B.A., Munro, C.L., Elswick, R.K., Robins, J.L., Ferreira-Gonzalez,A., Baliko,B.,
Kapowitz, L.G., Garrett, C.T., Brigle, K.E., Kendall, L.C., Lucas, V.S., Cochran, K.L. (2003). Effects of
stress management on PNI-based outcomes in persons with HIV disease. Research in Nursing and
Health, March 102-117.
 Pandak, W.M., Stravitz, R.T., Lucas, V.S., Heuman, D.M., Chiang, Y.L. (1996). HepG2 cells: A model
for studies on regulation of human cholesterol 7-alpha-hydroxylase at the molecular level. American
Journal of Physiology, March 401-410.
ABSTRACTS
 Aesthetic Inquiry: An emerging qualitative method. V. Lucas, J. DellaRipa, B. Biddle. School of Nursing.
Virginia Commmonwealth University, Richmond, VA 23298. Presented at Southern Nursing Research
Society Meeting, Baltimore, MD, February 2009.
 Cytokine patterns, neuroendocrine mediators, and psychosocial variables in HIV disease. N. McCain, B.
Munjas, C. Munro, R.K. Elswick, P. Kimball, A. Ferriera-Gonzalez, L. Kaplowitz, E. Fisher, C. Garrett, K.
Brigle, L. Kendall, V. Lucas and J. Robbins. School of Nursing, Virginia Commonwealth
University/Medical College of Virginia, Richmond, VA 23298.
 Alterations in cholesterol/bile acid homeostasis following over expression of cholesterol 7-alphahydroxylase using a CMV-C7alphaH adenoviral construct. C. Schwarz, D. Mallonee, Z.R. Vlahcevic, P.B.
Hylemon, V. Lucas, J. Y. L. Chiang, K. Valerie and W.M. Pandak. Departments of Medicine and
Microbiology, Virginia Commonwealth University/Medical College of Virginia, Richmond, VA 23298.
 Expression of fibroblast growth factor in the developing nervous system. Neuberger, T.J., Sage,
B.V.**, Russell, T., and DeVries, G.H. Dept. of Biochemistry and Molecular Biophysics, Medical College
of Virginia. 23298
 Expression of fibroblast growth factor in the PNS during development and after injury. Neuberger, T.J.,
Sage, B.V.** and DeVries, G.H. Dept. of Biochemistry and Molecular Biophysics, Medical College of
Virginia. 23298
 Fibroblast growth factor in the nervous system during development and after injury. Neuberger, T.J.,
Sage, B.V.** and DeVries, G.H. (Cornbrooks, C.J.) Dept. of Biochemistry and Molecular Biophysics,
Medical College of Virginia. 23298
**Please note B.V. Sage is my maiden name.
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CME PRESENTATIONS
 High Tech Whizardry and Wound Therapy: The Latest Technologies, Virginia Geriatrics Society Annual
Conference, Williamsburg, VA 4/10/10
 Wound Healing for the Plastic Surgery Nurse, American Society of Plastic Surgical Nurses Annual
Conference, Baltimore, 10/29/07
 Protecting the Skin: The Peri-operative Nurses Role, Association of Operating Room Nurses, Richmond
Region, Richmond AORN Workshop, 2/24/07
 Wound Care Product Update, VCUHS Dermatology Grand Rounds, 11/06; 11/07; 2/08; 3/09
 Pressure Ulcers: Assessment and Treatment Strategies for the Spinal Cord Injured Patient, 15th Annual
Spinal Cord Injury Symposium, Virginia Beach, VA 10/2/06
 Lower Extremity Ulcers, VCUHS Wound Healing Conference, Richmond, VA Fall 2005
 Wounds and Wound Care: Understanding Dressing Selection, VCU School of Medicine M4 update
course, Annually Spring 2002 - 2005
 Uncommon Wounds, presented at VCUHS Wound Care Conference, Richmond, VA Fall 2003
 Options for Wound Care, VCUHS Dermatology Grand Rounds, annually from 2001-2005
 Nursing Considerations in Breast Reconstruction, Women’s Health Clinical Byte, VCUHS Dept of
Education and Professional Development. Fall 2004, Fall 2005 and repeated 10/26/06
 Wounds and Wound Care: A Primer, VCUHS Internal Medicine Grand Rounds, Fall 2004
 Wound Healing and Dressing Options, VCUHS Nurse Practitioner Grand Rounds, Spring2002
 Options for Wound Care, VCUHS Geriatric Grand Rounds, Winter 2002
HONORS
 Editor’s Award, Plastic Surgical Nursing, December 2011
 Southern Nursing Research Society’s Dissertation Grant Award, February 2011
 VCU School of Nursing Doctoral Program Committee – student representative 2009-2011
 Barbara Farley Graduate Nursing Student Award – Spring 2009
 Hill-Rom Clinical Advisory Board, March 2009.
 VCUHS Excellence in Advanced Practice Nursing Award – Spring 2005
 Sigma Theta Tau Research Award – Spring 1999
 Professional Nurse Traineeship Funds – applied toward educational expenses for 1997 – 1999.
 VCU/MCV School of Nursing Promotion and Tenure Peer Review Committee – student representative
1999, 2007
 Graduated Summa Cum Laude, December 1997
COMMUNITY ACTIVITIES, ORGANIZATIONAL MEMBERSHIP
 Peer Reviewer – American Journal of Critical Care, Jan 2010
 VCUHS Tissue Use Committee (June 2009 – present)
 VCUHS Institutional Review Board (2006 – present)
 American Society of Plastic Surgery Nurses (2004 – present)
 Southern Nursing Research Society (2006 – present)
 Book Reviewer, Journal of Plastic Surgery Nursing (2006 – present)
 Planning Committee, VCUHS Biannual Wound Healing Symposiums (2003, 2005, 2007, 2009, 2011)
 Association for the Advancement of Wound Healing (2000 – present)
 Sigma Theta Tau Nursing Honor Society (1997 – present),
Nominations Committee Chair (1999-2001)
Vice-President (2001-2002)
Program Committee Chair (2001-2002)
 National and State Nursing Association (1998 – present)
 Co-Chair, VCUHS Standards of Practice Committee (2001-2002)
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Virginia Council of Nurse Practitioners (1997 – present)
Chair of Legislative Committee-Richmond Region (2001-2003)
American Academy of Nurse Practitioners (1999 – present)
Woodland Heights Civic Association (1992 – 2004)
Fan Free Clinic – Volunteer health care provider (1999-2002)
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